,#FILEFORMAT= gene_annV0.4.1,,,,,,,,,,,,,,,,,
,#FILEDATE=2020.04.20,,,,,,,,,,,,,,,,,
no,Field_Name,source_name,source_version,schema_title,Description,Comments,Link,value_example (separated by ';'),is_list,sub_embedding_group (SUBEMBEDDED OBJECT GROUPING),"field_type (string, integer, boolean, number)","SEPARATOR (comma, pipe, semicolon, colon, tab, tilde) ",enum_list (limit values to this list),do_import,FIELD_PRIORITY (order lookup number),COLUMN_PRIORITY (order/lookup number),FACET_GROUPING,FACET_PRIORITY
1,chrom,ENSEMBLgene,v99,Chromosome,name of the chromosome or scaffold; chromosome names without a 'chr',,,1; 2; 3; 4; 5; 6; 7; X; 8; 9,N,,string,,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,X,Y,M",Y,,,,
2,spos,ENSEMBLgene,v99,Start position,start position,,,11869; 14404; 17369; 29554; 30366; 34554; 52473; 57598; 65419; 89295,N,,integer,,,Y,,,,
3,epos,ENSEMBLgene,v99,End position,end position,,,14409; 29570; 17436; 31109; 30503; 36081; 53312; 64116; 71585; 133723,N,,integer,,,Y,,,,
3.5,strand,ENSEMBLgene,v99,Strand,,,,,N,,string,,"""+, -, .""",y,,,,
4,ensgid,ENSEMBLgene,v99,ENSEMBL gene ID,The stable identifier for the gene,,https://useast.ensembl.org/Homo_sapiens/Gene/Summary?g=<ID>,ENSG00000223972; ENSG00000227232; ENSG00000278267; ENSG00000243485; ENSG00000284332; ENSG00000237613; ENSG00000268020; ENSG00000240361; ENSG00000186092; ENSG00000238009,N,,string,,,Y,,,,
5,gene_version,ENSEMBLgene,v99,ENSEMBL gene version,The stable identifier version for the gene,,,5; 1; 2; 3; 6; 7; 4; 10; 12; 11,N,,string,,,Y,,,,
6,gene_symbol,ENSEMBLgene,v99,Gene symbol,The official symbol of this gene,Present NCBI or HUGO Name as the default,,DDX11L1; WASH7P; MIR6859-1; MIR1302-2HG; MIR1302-2; FAM138A; OR4G4P; OR4G11P; OR4F5; AL627309.1,N,,string,,,Y,,,,
8,gene_biotype,ENSEMBLgene,v99,Gene biotype,The biotype of this gene,,,transcribed_unprocessed_pseudogene; unprocessed_pseudogene; miRNA; lncRNA; protein_coding; processed_pseudogene; snRNA; transcribed_processed_pseudogene; misc_RNA; TEC,N,,string,,enum values?,Y,,,,
9,cytoband,CYTOBAND,2017-07-17,Cytoband,cytoband,,,1p36.33; 1p36.32; 1p36.31; 1p36.23; 1p36.22; 1p36.21; 1p36.13; 1p36.12; 1p36.11; 1p35.3,Y,,string,,,Y,,,,
10,gene_summary,RefSeq,2020-03-20,Gene summary,Gene summary from RefSeq,Default=CGAP KB; RefSeq if not available,,"The protein encoded by this gene is expressed in neurons of most regions of the brain. It contains an N-terminal BTB domain, which mediates dimerization of the protein, and a C-terminal Kelch domain, which mediates binding to F-actin. This protein may play a key role in the regulation of actin-based neuronal function. [provided by RefSeq, Aug 2010].; The protein encoded by this gene is a ubiquitin-like protein that is conjugated to intracellular target proteins upon activation by interferon-alpha and interferon-beta. Several functions have been ascribed to the encoded protein, including chemotactic activity towards neutrophils, direction of ligated target proteins to intermediate filaments, cell-to-cell signaling, and antiviral activity during viral infections. While conjugates of this protein have been found to be noncovalently attached to intermediate filaments, this protein is sometimes secreted. [provided by RefSeq, Dec 2012].; This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015].; The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation. [provided by RefSeq, Jul 2008].; This gene encodes a stromal cell derived factor that is a member of the CREC protein family. The encoded protein contains six EF-hand motifs and calcium-binding motifs. This protein localizes to the Golgi lumen and may be involved in regulating calcium dependent cellular activities. [provided by RefSeq, Sep 2011].; DVL1, the human homolog of the Drosophila dishevelled gene (dsh) encodes a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental processes, including segmentation and neuroblast specification. DVL1 is a candidate gene for neuroblastomatous transformation. The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1. The phenotypes of these diseases may be consistent with defects which might be expected from aberrant expression of a DVL gene during development. [provided by RefSeq, Jul 2008].; The protein encoded by this gene belongs to the cyclin family. Through its interaction with several proteins, such as RNA polymerase II, splicing factors, and cyclin-dependent kinases, this protein functions as a regulator of the pre-mRNA splicing process, as well as in inducing apoptosis by modulating the expression of apoptotic and antiapoptotic proteins. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]. COMPLETENESS: complete on the 3' end.; This gene encodes a transmembrane-domain containing protein found in the brain and cerebellum. Mutations in this gene result in spinocerebellar ataxia 21. [provided by RefSeq, Dec 2014].; The protein encoded by this gene is an E3 ubiquitin protein ligase that mediates ubiquitination of proteins in the Notch signaling pathway. The encoded protein may be a suppressor of melanoma invasion. [provided by RefSeq, Mar 2017].; This gene encodes a member of the serine/threonine protein kinase family. Members of this kinase family are known to be essential for eukaryotic cell cycle control. Due to a segmental duplication, this gene shares very high sequence identity with a neighboring gene. These two genes are frequently deleted or altered in neuroblastoma. The protein kinase encoded by this gene can be cleaved by caspases and may play a role in cell apoptosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015].",N,,string,,,Y,,,,
11,hgnc_id,HGNC,2020-02-24,HGNC ID,A unique ID provided by the HGNC for each gene with an approved symbol.,,https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:<ID>,37102; 38034; 50039; 52482; 35294; 32334; 14822; 31276; 14825; 48835,N,,string,,,Y,,,dbxref,
12,name,HGNC,2020-02-24,Gene full name,The full gene name approved by the HGNC.,Default ,,"DEAD/H-box helicase 11 like 1; WASP family homolog 7, pseudogene; microRNA 6859-1; MIR1302-2 host gene; microRNA 1302-2; family with sequence similarity 138 member A; olfactory receptor family 4 subfamily G member 4 pseudogene; olfactory receptor family 4 subfamily G member 11 pseudogene; olfactory receptor family 4 subfamily F member 5; capicua transcriptional repressor pseudogene 27",N,,string,,,Y,,,,
19,entrez_id,HGNC,2020-02-24,NCBI Gene,NCBI Gene ID,,https://www.ncbi.nlm.nih.gov/gene/<ID>,100287102; 653635; 102466751; 107985730; 100302278; 645520; 79504; 403263; 79501; 100420257,N,,string,,,Y,,,dbxref,
21,ucsc_id,HGNC,2020-02-24,UCSC,UCSC genome browser gene ID,,,uc031tlb.1; uc001aak.4; uc001aal.1; uc010nxu.2; uc010nxv.2; uc031tlt.2; uc010nxx.3; uc001abt.5; uc001abw.2; uc001abz.5,N,,string,,,Y,,,dbxref,
22,refseq_accession,HGNC,2020-02-24,RefSeq,The Reference Sequence (RefSeq) collection,,https://www.ncbi.nlm.nih.gov/gene/?term=<ID>,NR_046018; NR_024540; NR_106918; XR_001737835; NR_036051; NR_026818; NG_004148; NG_004423; NM_001005484; NG_027060,Y,,string,,,Y,,,dbxref,
23,ccds_id,HGNC,2020-02-24,CCDS,The Consensus CDS (CCDS) project: a collaborative effort to identify a core set of human and mouse protein coding regions that are consistently annotated and of high quality,,https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?REQUEST=CCDS&DATA=<ID>,CCDS30547; CCDS72675; CCDS41221; CCDS2; CCDS3; CCDS30550; CCDS4|CCDS53256; CCDS76083; CCDS5|CCDS44034; CCDS6,Y,,string,,,Y,,,dbxref,
24,uniprot_ids,HGNC,2020-02-24,UniProt,UniProt accession number,,https://www.uniprot.org/uniprot/<ID>,Q8NH21; Q6IEY1; Q96NU1; Q9Y3T9; Q6TDP4; Q494U1; Q5SV97; Q9HCC6; P05161; O00468,Y,,string,,,Y,,,dbxref,
26,mgd_id,HGNC,2020-02-24,MGI,Mouse Genome Informatics Database,We need to look at one mouse db at least,http://www.informatics.jax.org/marker/<ID>,MGI:3031137; MGI:2446220; MGI:1931051; MGI:2678948; MGI:2387630; MGI:1921433; MGI:1855694; MGI:87961; MGI:3588193; MGI:2444364,Y,,string,,,Y,,,dbxref,
30,omim_id,HGNC,2020-02-24,OMIM,Online Mendelian Inheritance in Man (OMIM),,https://omim.org/entry/<ID>,616765; 610770; 615921; 608060; 147571; 103320; 612091; 612090; 612094; 603905,Y,,string,,,Y,,,dbxref,
34,orphanet,HGNC,2020-02-24,OrphaNet,portal for rare diseases and orphan drugs,,https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=<ID>,315470; 233062; 434205; 356939; 426034; 469968; 412653; 470030; 121991; 311140,N,,string,,,Y,,,dbxref,
36,ClinGen,ClinGen,20200309,ClinGen,ClinGen,Keep as a link,https://search.clinicalgenome.org/kb/genes/HGNC:<ID>,329; 17978; 4396; 10896; 12003; 19104; 13281; 29105; 18806; 16369,N,,string,,,Y,,,dbxref,
41,disease_label,ClinGenDisease,20200309,Disease Label,Disease label list,,,Shprintzen-Goldberg syndrome; nonsyndromic genetic deafness|nonsyndromic genetic deafness; homocystinuria due to methylene tetrahydrofolate reductase deficiency; hyperprolinemia type 2; C1Q deficiency; 3-hydroxy-3-methylglutaric aciduria; hypertrophic cardiomyopathy; nonsyndromic genetic deafness|erythrokeratodermia variabilis; Stickler syndrome; nonsyndromic genetic deafness,Y,clingendis,string,,,Y,,,,
42,disease_id,ClinGenDisease,20200309,Disease ID (MONDO),,,https://search.clinicalgenome.org/kb/conditions/<ID>,MONDO_0008426; MONDO_0019497|MONDO_0019497; MONDO_0009353; MONDO_0009401; MONDO_0013343; MONDO_0009520; MONDO_0005045; MONDO_0019497|MONDO_0017851; MONDO_0019354; MONDO_0019497,Y,clingendis,string,,,Y,,,,
43,Inheritance,ClinGenDisease,20200309,Inheritance,,,,Autosomal Dominant; Autosomal Dominant|Autosomal Recessive; Autosomal Recessive; Autosomal Dominant|Autosomal Dominant; Autosomal Dominant|Autosomal Recessive|Autosomal Dominant|Autosomal Dominant|Autosomal Recessive|Autosomal Recessive; Autosomal Recessive|Autosomal Dominant; Autosomal Dominant|Autosomal Dominant|Autosomal Dominant|Autosomal Dominant|Autosomal Dominant; Autosomal Dominant|Autosomal Recessive|Autosomal Dominant; Autosomal Dominant|Autosomal Dominant|Autosomal Recessive; Autosomal Dominant|Autosomal Dominant|Autosomal Dominant|Autosomal Dominant,Y,clingendis,string,,,Y,,,,
44,classification,ClinGenDisease,20200309,Classification,,,,Definitive; Limited|Definitive; Moderate; Limited; Disputed|Strong; Moderate|Definitive|Limited|No Reported Evidence|Limited|No Reported Evidence; Definitive|Moderate; Strong; Disputed; Limited|No Reported Evidence|Limited|Definitive|Limited,Y,clingendis,string,,,Y,,,,
47,Ensembl_TRS,ENSEMBLIDxref,v2.1.1,ENSEMBL transcript,ENSEMBL transcript ID list,,https://useast.ensembl.org/Homo_sapiens/Transcript/Summary?t=<ID>,ENST00000641515|ENST00000335137; ENST00000426406|ENST00000426406; ENST00000332831|ENST00000332831; ENST00000420190|ENST00000437963|ENST00000342066|ENST00000341065|ENST00000455979|ENST00000618181|ENST00000622503|ENST00000618323|ENST00000616016|ENST00000618779|ENST00000616125|ENST00000620200|ENST00000617307; ENST00000327044; ENST00000338591|ENST00000466300|ENST00000622660; ENST00000379410|ENST00000379409|ENST00000379407|ENST00000491024; ENST00000341290|ENST00000433179; ENST00000428771|ENST00000304952|ENST00000484667; ENST00000624697|ENST00000624652|ENST00000649529,N,transcriptid,string,,,Y,,,,
48,Ensembl_PRO,ENSEMBLIDxref,v2.1.1,ENSEMBL protein,ENSEMBL protein ID list,,http://www.ensembl.org/Homo_sapiens/protview?peptide=<ID>,ENSP00000493376|ENSP00000334393; ENSP00000409316|ENSP00000409316; ENSP00000329982|ENSP00000329982; ENSP00000411579|ENSP00000393181|ENSP00000342313|ENSP00000349216|ENSP00000412228|ENSP00000480870|ENSP00000482138|ENSP00000480678|ENSP00000478421|ENSP00000484256|ENSP00000484643|ENSP00000484820|ENSP00000482090; ENSP00000317992; ENSP00000343930|ENSP00000463694|ENSP00000479477; ENSP00000368720|ENSP00000368719|ENSP00000368717|ENSP00000462558; ENSP00000343864|ENSP00000414022; ENSP00000393198|ENSP00000304595|ENSP00000425085; ENSP00000485643|ENSP00000485313|ENSP00000496832,N,transcriptid,string,,,Y,,,,
55,PDB,ENSEMBLIDxref,v2.1.1,PDB,"The Protein Data Bank (PDB) [1] is a database for the three-dimensional structural data of large biological molecules, such as proteins and nucleic acids.",,https://www.rcsb.org/structure/<ID>,6HRL; 5KZ5|5WKP|5WLW|6NZU|1Z2M|2HJ8|3PHX|3PSE|3R66|3RT3|3SDL|5TL6|5W8T|5W8U|6BI8|6FFA; 2X9E|2ZMC|2ZMD|3CEK|3DBQ|3GFW|3H9F|3HMN|3HMO|3HMP|3VQU|3W1F|3WYX|3WYY|3WZJ|3WZK|4B94|4BHZ|4BI0|4BI1|4BI2|4C4E|4C4F|4C4G|4C4H|4C4I|4C4J|4CV8|4CV9|4CVA|4D2S|4H7X|4H7Y|4JS8|4JT3|4O6L|4ZEG|5AP0|5AP1|5AP2|5AP3|5AP4|5AP5|5AP6|5AP7|5EH0|5EHL|5EHO|5EHY|5EI2|5EI6|5EI8|5LJJ|5MRB|5N7V|5N84|5N87|5N93|5N9S|5NA0|5NAD|5NTT|5O91|6B4W|6GVJ|6H3K|6N6O; 1OQD|1XU2|2KN1|4ZFO|6J7W; 1RF3|4MXW|1D0A|2HEV|2HEY|6OGX|6OKM|6OKN; 1UPK|1UPL|2WTK|3GNI|4FZA|4FZD|4FZF|4NZW|4O27; 2F4W; 6BQN; 6IF3; 5KKP,Y,,string,,,Y,,,dbxref,
56,BioGrid,ENSEMBLIDxref,v2.1.1,BioGrid,BioGRID is an interaction repository with data compiled through comprehensive curation efforts.,,https://thebiogrid.org/<ID>,126661; 123224; 132958; 110207; 117038; 124318; 569148; 113123; 107080; 110233,Y,,string,,,Y,,,dbxref,
59,STRING,ENSEMBLIDxref,v2.1.1,STRING,STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) is a biological database and web resource of known and predicted proteinâ€“protein interactions.,,https://string-db.org/network/<ID>,9606.ENSP00000317482; 9606.ENSP00000386195; 9606.ENSP00000358902; 9606.ENSP00000419457; 9606.ENSP00000332791; 9606.ENSP00000417003; 9606.ENSP00000262290; 9606.ENSP00000367130; 9606.ENSP00000310623; 9606.ENSP00000273352,Y,,string,,,Y,,,dbxref,
70,GeneCards,ENSEMBLIDxref,v2.1.1,GeneCards,"a database of human genes that provides genomic, proteomic, transcriptomic, genetic and functional information on all known and predicted human genes.",link,https://www.genecards.org/cgi-bin/carddisp.pl?gene=<ID>,OR4F4; OR4E2; SAMD10; NOBOX; KLHL15; PLEKHM3; LPO; HES3; ISCU; ADGRG7,Y,,string,,,Y,,,dbxref,
73,PharmGKB,ENSEMBLIDxref,v2.1.1,PharmGKB,"a publicly available, online knowledgebase responsible for the aggregation, curation, integration and dissemination of knowledge regarding the impact of human genetic variation on drug response.",PGx- manul MVP,https://www.pharmgkb.org/gene/<ID>,PA32290; PA32278; PA25678; PA134934728; PA162399738; PA30439; PA142671692; PA162392328; PA134982718; PA164725453,Y,,string,,,Y,,,dbxref,
93,GeneReviews,ENSEMBLIDxref,v2.1.1,GeneReviews,GeneReviews,,https://www.ncbi.nlm.nih.gov/books/NBK1116/?term=<ID>%5BGeneSymbol%5D,ISCU; CPT2; GABRB3; SKIV2L; MMADHC; WRN; NPHP3; KIF1A; PEX13; CLCN5,Y,,string,,,Y,,,dbxref,
109,Pathway(KEGG)_id,dbNSFP,4.0c,KEGG,ID(s) of the Pathway(s) the gene belongs to (from KEGG),,https://www.genome.jp/dbget-bin/www_bget?<ID>,hsa04740; hsa04512; hsa04060; hsa00532;hsa01030; hsa04120;hsa05020; hsa04742; hsa04310;hsa04330;hsa04916;hsa05210;hsa05217; hsa00760; hsa04020;hsa04070;hsa04720;hsa04740;hsa04910;hsa04912;hsa04916;hsa05040;hsa05214; hsa04080,N,,string,,,Y,,,dbxref,
110,Pathway(KEGG)_full,dbNSFP,4.0c,KEGG pathway,Full name(s) of the Pathway(s) the gene belongs to (from KEGG),,,Olfactory transduction; ECM-receptor interaction; Cytokine-cytokine receptor interaction; Chondroitin sulfate biosynthesis;Glycan structures - biosynthesis 1; Ubiquitin mediated proteolysis;Parkinson's disease; Taste transduction; Wnt signaling pathway;Notch signaling pathway;Melanogenesis;Colorectal cancer;Basal cell carcinoma; Nicotinate and nicotinamide metabolism; Calcium signaling pathway;Phosphatidylinositol signaling system;Long-term potentiation;Olfactory transduction;Insulin signaling pathway;GnRH signaling pathway;Melanogenesis;Huntington's disease;Glioma; Neuroactive ligand-receptor interaction,N,,string,,,Y,,,dbxref,
118,Trait_association(GWAS),dbNSFP,4.0c,GWAS catalog trait,Trait(s) the gene associated with (from GWAS catalog),Discuss UI/UX,,"Subjective response to lithium treatment; Morning vs. evening chronotype; Pancreatic cancer; Parkinson's disease; Blood protein levels; Large artery stroke|Lead levels|Height; Inflammatory bowel disease; Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy); Systemic lupus erythematosus; Inflammatory bowel disease|Systemic lupus erythematosus|Ulcerative colitis",Y,,string,,,Y,,,,
119,Trait_association(GWAS)_PMID,dbNSFP,4.0c,GWAS catalog trait PMID,Trait(s) the gene associated with (from GWAS catalog),,https://www.ebi.ac.uk/gwas/publications/<ID>,26503763; 26955885; 29422604; 26227905; 29875488~30072576; 24262325|26025379|21998595; 23128233; 26974007; 30072576; 28714469,Y,,string,,,Y,,,,
138,RVIS_ExAC,dbNSFP,4.0c,RVIS(ExAC),ExAC-based RVIS; setting 'common' MAF filter at 0.05% in at least one of the six individual ethnic strata from ExAC.,,,2.274410941; 0.231569638; -1.365209057; 1.879999506; 0.410434686; 0.70374788; -0.175667739; 1.24272779; 0.691137693; 0.500554195,N,,number,,,Y,,,,
139,RVIS_percentile_ExAC,dbNSFP,4.0c,RVIS(ExAC) percentile,Genome-Wide percentile for the new ExAC-based RVIS; setting 'common' MAF filter at 0.05% in at least one of the six individual ethnic strata from ExAC.,,,98.9036805; 65.47195952; 4.843081742; 97.96397807; 74.54370219; 85.01897476; 38.31696886; 94.1569785; 84.63947955; 78.2482983,N,,number,,,Y,,,,
157,GDI-Phred,dbNSFP,4.0c,GDI phred score,Phred-scaled GDI scores,??also change to no??,,2.31572; 5.65821; 5.53337; 1.58809; 5.29021; 7.82660; 6.95277; 6.86990; 3.96842; 1.51792,N,,number,,,Y,,,,
158,GDP,dbNSFP,4.0c,Gene damage prediction (all disease-causing genes),gene damage prediction (low/medium/high) by GDI for all diseases,,,Medium; High; Low,N,,string,,,Y,,,,
183,MGI_mouse_gene,dbNSFP,4.0c,Mouse gene (MGI),Homolog mouse gene name from MGI,,,Olfr1303; Samd11; Noc2l; Klhl17; Plekhn1; Perm1; Isg15; Agrn; Rnf223; 9430015G10Rik,N,,string,,"Medium, High, Low",Y,,,,
184,MGI_mouse_phenotype,dbNSFP,4.0c,Mouse phenotype (MGI),Phenotype description for the homolog mouse gene from MGI,,,"endocrine/exocrine gland phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; skeleton phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; homeostasis/metabolism phenotype; hematopoietic system phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; liver/biliary system phenotype; growth/size/body region phenotype; taste/olfaction phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan)",N,,string,,,Y,,,,
189,gnomAD,gnomADmetrics,v2.1.1,gnomAD,gnomAD gene,,https://gnomad.broadinstitute.org/gene/<ID>,ENSG00000186092; ENSG00000187634; ENSG00000188976; ENSG00000187961; ENSG00000187583; ENSG00000187642; ENSG00000188290; ENSG00000187608; ENSG00000188157; ENSG00000237330,N,,string,,,Y,,,,
190,obs_mis,gnomADmetrics,v2.1.1,Observed missense,,,,67; 546; 577; 467; 480; 422; 103; 117; 1303; 124,N,,integer,,,Y,,,,
191,exp_mis,gnomADmetrics,v2.1.1,Expected missense,,,,8.2715e+01; 3.6202e+02; 4.6201e+02; 4.3355e+02; 3.8117e+02; 3.9110e+02; 9.0430e+01; 1.1566e+02; 1.3261e+03; 1.0779e+02,N,,number,,,Y,,,,
192,oe_mis,gnomADmetrics,v2.1.1,o/e (missense),,,,8.1001e-01; 1.5082e+00; 1.2489e+00; 1.0772e+00; 1.2593e+00; 1.0790e+00; 1.1390e+00; 1.0115e+00; 9.8257e-01; 1.1504e+00,N,,number,,,Y,,,gene metrics,
199,obs_syn,gnomADmetrics,v2.1.1,Observed synonymous,,,,28; 270; 320; 360; 216; 215; 53; 63; 727; 58,N,,integer,,,Y,,,,
200,exp_syn,gnomADmetrics,v2.1.1,Expected synonymous,,,,3.0512e+01; 1.5898e+02; 1.9938e+02; 2.0109e+02; 1.7452e+02; 1.7481e+02; 4.1769e+01; 5.8149e+01; 6.0335e+02; 5.0639e+01,N,,number,,,Y,,,,
201,oe_syn,gnomADmetrics,v2.1.1,o/e (synonymous),,,,9.1766e-01; 1.6983e+00; 1.6049e+00; 1.7903e+00; 1.2377e+00; 1.2299e+00; 1.2689e+00; 1.0834e+00; 1.2049e+00; 1.1454e+00,N,,number,,,Y,,,gene metrics,
204,obs_lof,gnomADmetrics,v2.1.1,Observed LoF,,,,2; 22; 43; 26; 25; 21; 6; 0; 29; 7,N,,integer,,,Y,,,,
205,exp_lof,gnomADmetrics,v2.1.1,Expected LoF,,,,2.3369e+00; 2.4538e+01; 4.1785e+01; 2.8650e+01; 3.1069e+01; 1.7757e+01; 3.5300e+00; 1.1056e+00; 9.0870e+01; 2.1002e+00,N,,number,,,Y,,,,
206,oe_lof,gnomADmetrics,v2.1.1,o/e (LoF),,,,8.5584e-01; 8.9656e-01; 1.0291e+00; 9.0749e-01; 8.0467e-01; 1.1826e+00; 1.6997e+00; 0.0000e+00; 3.1914e-01; 9.5227e-01,N,,number,,,Y,,,gene metrics,
251,cds_length,gnomADmetrics,v2.1.1,CDS length,,,,915; 2043; 2247; 1926; 1833; 2088; 741; 495; 6135; 747,N,,integer,,,Y,,,,
252,num_coding_exons,gnomADmetrics,v2.1.1,Number of coding exons,,,,1; 13; 19; 12; 16; 5; 3; 2; 36; 8,N,,integer,,,Y,,,,
313,Marrvel,Marrvel,v1.2,Marrvel,Integrated information from six human genetic databases and seven model organism databases,,http://www.marrvel.org/search/gene/<ID>,DDX11L1;WASH7P;FAM138A;OR4G4P;OR4G11P;OR4F5;CICP27;WASH9P;WBP1LP7;OR4F29;CICP7;WBP1LP6;OR4F16;CICP3;FAM87B;FAM41C;TUBB8P11;SAMD11;NOC2L;KLHL17,N,,string,,,Y,,,,
314,s_het,CassaNatGenet2017,04/03/2017,s_het,s_het estimates based on ExAC should be here http://genetics.bwh.harvard.edu/genescores/,,,0.712744609;0.687495742;0.660254755;0.639410094;0.620360495;0.616952455;0.615396766;0.608889049;0.598649548;0.586267656;0.583941063;0.573090113;0.552121239;0.547772441;0.547290214;0.547052978;0.542223592;0.541479417;0.536996463,N,,number,,,Y,,,,
315,gtex_expression,GTEx,v8,GTEx,,,https://gtexportal.org/home/gene/<ID>,ENSG00000070669.12,N,,string,,,Y,,,,
316,brainspan_rnaseq,BrainSpan,March.2013,BrainSpan RNAseq,,,https://www.brainspan.org/rnaseq/searches?exact_match=false&search_term=<ID>,ENSG00000070669,N,,string,,,Y,,,,
317,brainspan_microarray,BrainSpan,March.2013,BrainSpan Microarray,,,https://www.brainspan.org/lcm/search?exact_match=false&search_term=%<ID>%22&search_type=gene,BRCA,N,,string,,,Y,,,,
318,brainatlas_microarray,BrainAtlas,March.2013,BrainAtlas Microarray,,,https://human.brain-map.org/microarray/search/show?exact_match=false&search_term=%22<ID>%22&search_type=gene,BRCA,N,,string,,,Y,,,,
319,enstid,GenCode,v33,ENSEMBL transcript ID,,,,,,transcript,string,,,Y,,,,
320,enspid,GenCode,v33,ENSEMBL protein ID,,,,,,transcript,string,,,Y,,,,
321,refseq,GenCode,v33,RefSeq ID,,,,,,transcript,string,,,Y,,,,
322,refseq_protein,GenCode,v33,RefSeq Protein ID,,,,,,transcript,string,,,Y,,,,
323,pos,GenCode,v33,position,,,,,,transcript,string,,,Y,,,,
324,exon,GenCode,v33,Exon region position,,,,,,transcript,string,,,Y,,,,
325,CDS,GenCode,v33,CDS region postion,,,,,,transcript,string,,,Y,,,,
326,start_codon,GenCode,v33,Start codon position,,,,,,transcript,string,,,Y,,,,
327,stop_codon,GenCode,v33,Stop codon position,,,,,,transcript,string,,,Y,,,,
328,five_prime_UTR,GenCode,v33,5' UTR position,,,,,,transcript,string,,,Y,,,,
329,three_prime_UTR,GenCode,v33,3' UTR position,,,,,,transcript,string,,,Y,,,,
330,transcript_length,GenCode,v33,Transcript sequence length,,,,,,transcript,string,,,Y,,,,
331,transcript_sequence,GenCode,v33,Transcript sequence,,,,,,transcript,string,,,Y,,,,
332,protein_length,GenCode,v33,Protein sequence length,,,,,,transcript,string,,,Y,,,,
333,protein_sequence,GenCode,v33,Protein sequence,,,,,,transcript,string,,,Y,,,,
7,gene_source,ENSEMBLgene,v99,Gene source,The annotation source for this gene,,,havana; mirbase; ensembl_havana; ensembl; havana_tagene; insdc,N,,,,,N,,,,
13,locus_group,HGNC,2020-02-24,Locus group,,,,pseudogene; non-coding RNA; protein-coding gene; other,N,,,,,N,,,,
14,locus_type,HGNC,2020-02-24,Locus type,Specifies the genetic class of each gene entry.,,,"pseudogene; RNA, micro; RNA, long non-coding; gene with protein product; readthrough; RNA, small nuclear; RNA, small nucleolar; unknown; immunoglobulin pseudogene; endogenous retrovirus",N,,,,,N,,,,
15,alias_symbol,HGNC,2020-02-24,Alias gene symbol,Alias gene symbol,,,FAM39F; hsa-mir-6859-1; hsa-mir-1302-2; F379; hsa-mir-6859-2; FLJ40008; FLJ22639; AL645608.1; MGC45873; DKFZP564C186|NET7|NET15|NIR|PPP1R112,Y,,,,,N,,,,
16,alias_name,HGNC,2020-02-24,Alias gene name,Alias gene name,,,"family with sequence similarity 39, member F; novel INHAT repressor|protein phosphatase 1, regulatory subunit 12; actinfilin; PGC-1- and ERR-induced regulator in muscle 1; calcium binding protein; beta-1,3-galactosyltransferase-6; adipolin|adipose-derived insulin-sensitizing factor; limitrin; cyclin S; matrix metalloproteinase 22|femalysin|matrix metalloproteinase in the female reproductive tract",Y,,,,,N,,,,
17,prev_symbol,HGNC,2020-02-24,Previous gene symbol,This field displays any symbols that were previously HGNC-approved nomenclature.,,,MIRN1302-2; NCRNA00115; C1orf170; G1P2; AGRIN; MIRN200B; MIRN200A; MIRN429; TTLL5; TXGP1L,Y,,,,,N,,,,
18,prev_name,HGNC,2020-02-24,Previous gene name,This field displays any names that were previously HGNC-approved nomenclature.,,,"DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 like 1|DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 1; WAS protein family homolog 7, pseudogene; family with sequence similarity 138, member A; olfactory receptor, family 4, subfamily G, member 4 pseudogene; olfactory receptor, family 4, subfamily G, member 11 pseudogene; olfactory receptor, family 4, subfamily F, member 5; WW domain binding protein 1-like pseudogene 7; olfactory receptor, family 4, subfamily F, member 29; capicua homolog (Drosophila) pseudogene 7; mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 23",Y,,,,,N,,,,
20,vega_id,HGNC,2020-02-24,VEGA,,,http://vega.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=<ID>,OTTHUMG00000000961; OTTHUMG00000000958; OTTHUMG00000000959; OTTHUMG00000000960; OTTHUMG00000185779; OTTHUMG00000001095; OTTHUMG00000001094; OTTHUMG00000001257; OTTHUMG00000191963; OTTHUMG00000002854,N,,,,,N,,,,
25,pubmed_id,HGNC,2020-02-24,PubMed,PubMed,,https://pubmed.ncbi.nlm.nih.gov/<ID>,19476624; 18159949; 11779631|15233989; 19123937; 14983052; 12477932; 29707762; 27734943; 20123734|22363708; 12063253,Y,,,,,N,,,,
27,rgd_id,HGNC,2020-02-24,MouseMine,,,http://ratmine.mcw.edu/ratmine/portal.do?externalids=<ID>&class=Gene&origin=MouseMine,RGD:1566059; RGD:1334011; RGD:1310271; RGD:1309387; RGD:708444; RGD:1311019; RGD:1304931; RGD:1310312; RGD:2067; RGD:1587009,Y,,,,,N,,,,
28,lsdb,HGNC,2020-02-24,LRG,A Locus Reference Genomic (LRG) record contains stable reference sequences that are used for reporting sequence variants with clinical implications,,,"LRG_1231|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_1231.xml; Leiden Muscular Dystrophy pages|http://www.dmd.nl/nmdb2/home.php?select_db=AGRN|LRG_198|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_198.xml; LRG_1319|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_1319.xml; LRG_1261|http://ftp.ebi.ac.uk/pub/databases/lrgex/pending/LRG_1261.xml; dbPEX, PEX Gene Database|http://www.dbpex.org/home.php?select_db=PEX10; LRG_827|http://ftp.ebi.ac.uk/pub/databases/lrgex/pending/LRG_827.xml; LRG_1281|http://ftp.ebi.ac.uk/pub/databases/lrgex/pending/LRG_1281.xml; LRG_262|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_262.xml; Parkinson's disease Mutation Database|http://grenada.lumc.nl/LOVD2/TPI/home.php?select_db=PARK7; LRG_1165|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_1165.xml",Y,,,,,N,,,,
29,cosmic,HGNC,2020-02-24,Cosmic,Catalog of somatic mutations in cancer,,https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=<ID>,OR4F5; OR4F29; OR4F16; FAM87B; SAMD11; NOC2L; KLHL17; PLEKHN1; HES4; ISG15,N,,,,,N,,,,
31,mirbase,HGNC,2020-02-24,miRBase,the microRNA database,,http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=<ID>,MI0022705; MI0006363; MI0026420; MI0000342; MI0000737; MI0001641; MI0022571; MI0022572; MI0022653; MI0015861,N,,,,,N,,,,
32,homeodb,HGNC,2020-02-24,HomeoDB,a database of homeobox gene diversity,,http://homeodb.zoo.ox.ac.uk/gene_info.get?id=<ID>&og=Human,8485; 8497; 8528; 8458; 8409; 8416; 8573; 8563; 8487; 8460,N,,,,,N,,,,
33,snornabase,HGNC,2020-02-24,snoRNABase,database of human H/ACA and C/D box snoRNAs,,https://www-snorna.biotoul.fr/plus.php?id=<ID>,SR0000241; SR0000002; SR0000003; SR0000004; SR0000005; SR0000006; SR0000007; SR0000008; SR0000012; SR0000013,N,,,,,N,,,,
35,enzyme_id,HGNC,2020-02-24,ENZYME,ENZYME database,,http://enzyme.expasy.org/EC/<ID>,2.7.1.23; 2.7.11.1; 3.1.4.11; 1.11.1.20; 2.1.1.100; 4.2.1.11; 4.2.1.1; 1.1.1.47; 2.7.1.153; 2.7.7.1,Y,,,,,N,,,,
37,clinical_validity,ClinGen,20200309,Clinical Validity,,V1,,Curated,N,,,,,N,,,,
38,evidence,ClinGen,20200309,Evidence-Based Summary,,V1,,Curated,N,,,,,N,,,,
39,haploinsufficiency_score,ClinGen,20200309,Haploinsufficiency Score,,V1,,Associated with Autosomal Recessive Phenotype; Minimal Evidence; No Evidence; Sufficient Evidence; Dosage Sensitivity Unlikely; Some Evidence,N,,,,,N,,,,
40,triplosensitivity_score,ClinGen,20200309,Triplosensitivity Score,,V1,,No Evidence; Minimal Evidence; Sufficient Evidence; Dosage Sensitivity Unlikely; Moderate Evidence,N,,,,,N,,,,
45,online_report,ClinGenDisease,20200309,Online report,,,,https://search.clinicalgenome.org/kb/gene-validity/4841; https://search.clinicalgenome.org/kb/gene-validity/9bdbd958-1ad2-447a-9ccd-ed86f308577a--2018-09-20T20:03:22|https://search.clinicalgenome.org/kb/gene-validity/7c63a581-ad69-4f18-b68b-d1b2cef5e699--2018-02-27T17:00:00; https://search.clinicalgenome.org/kb/gene-validity/cbfc5297-ed0d-4d7c-bca6-747114ed2b17--2019-06-18T16:00:00; https://search.clinicalgenome.org/kb/gene-validity/5edc3f72-31e0-47f8-bcec-e3e5b81c97ae--2019-09-13T17:27:15; https://search.clinicalgenome.org/kb/gene-validity/3216; https://search.clinicalgenome.org/kb/gene-validity/f4d084e5-a740-4bfd-a850-d6db900d4a4e--2018-06-26T16:00:00; https://search.clinicalgenome.org/kb/gene-validity/d9f35d3c-2d30-4947-9d10-87d21405586e--2018-08-01T16:33:16; https://search.clinicalgenome.org/kb/gene-validity/f83e013a-685f-405b-89d6-a8e80aefaf6e--2018-08-23T16:53:15|https://search.clinicalgenome.org/kb/gene-validity/1d48c959-31d8-44e2-985c-c48921e8f08a--2018-03-05T05:00:00; https://search.clinicalgenome.org/kb/gene-validity/697ae26e-2b07-4f87-b42c-121684c89bc0--2019-02-19T17:00:00; https://search.clinicalgenome.org/kb/gene-validity/88196c6d-4bd7-4aff-ba98-c7b4411c562d--2017-11-21T17:00:00,Y,clingendis,,,,N,,,,
46,classification_date,ClinGenDisease,20200309,Classification date,,,,2016-12-01 00:00:00; 2018-09-20 20:03:22.775|2018-02-27 17:00:00.000; 2019-06-18 16:00:00.000; 2019-09-13 17:27:15.767; 2017-01-09 00:00:00; 2018-06-26 16:00:00.000; 2018-08-01 16:33:16.590; 2018-08-23 16:53:15.195|2018-03-05 05:00:00.000; 2019-02-19 17:00:00.000; 2017-11-21 17:00:00.000,Y,clingendis,,,,N,,,,
49,UniRef100,ENSEMBLIDxref,v2.1.1,UinRef 100% sequence identity genes,UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into a single UniRef entry.,,https://www.uniprot.org/uniref/<ID>,UniRef100_A0A4Y7LJF4|UniRef100_Q8NH21|UniRef100_Q96R69; UniRef100_Q8NGC2|UniRef100_Q6IEY1|UniRef100_A0A0S2Z5W7; UniRef100_X5D9M6|UniRef100_A6PWC8|UniRef100_A0A0S4XQV4|UniRef100_I7FV93|UniRef100_Q9BYL1|UniRef100_Q96NU1|UniRef100_A0A493TFJ9|UniRef100_H7BY14|UniRef100_F2WG57|UniRef100_Q96NU1-2|UniRef100_A0A087WW16|UniRef100_A0A087WXB3|UniRef100_A0A087WYH2|UniRef100_A0A087WYW1|UniRef100_A0A087WV57|UniRef100_A0A087WX24|UniRef100_Q4GMY9|UniRef100_I7G285|UniRef100_A0A087X1G6|UniRef100_A0A087X1J5|UniRef100_A0A087X1H5|UniRef100_A0A087X223|UniRef100_Q9BVV2|UniRef100_A0A087X2A3|UniRef100_A0A087WWQ4|UniRef100_A0A087WYU3; UniRef100_O60393|UniRef100_Q9Y3T9; UniRef100_Q96M94|UniRef100_Q6TDP4|UniRef100_B4DWR6|UniRef100_J3QLT4|UniRef100_A0A0G2JL37|UniRef100_Q0VGE6; UniRef100_Q6ZWE6|UniRef100_Q494U1|UniRef100_J3KSL1|UniRef100_Q494U1-2; UniRef100_P22079|UniRef100_Q5SV97; UniRef100_F2X608|UniRef100_E9PB28|UniRef100_Q5TGS1|UniRef100_Q9HCC6|UniRef100_D6RCM9|UniRef100_D6REB3; UniRef100_B4E187|UniRef100_P05161|UniRef100_S6B6Q1|UniRef100_Q9H1K1; UniRef100_Q96K78|UniRef100_O00468|UniRef100_Q9BTA9|UniRef100_A0A494C0G5|UniRef100_A0A484HK63|UniRef100_A0A494C1I6|UniRef100_A0A087WY58,Y,,,,,N,,,,
50,UniRef90,ENSEMBLIDxref,v2.1.1,UinRef 90% sequence identity genes,"UniRef90 is built by clustering UniRef100 sequences such that each cluster is composed of sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a. seed sequence).",,https://www.uniprot.org/uniref/<ID>,UniRef90_P30686|UniRef90_Q8NGA8; UniRef90_Q8NGC2|UniRef90_Q6IEY1|UniRef90_A0A2K5VRT4; UniRef90_X5D9M6|UniRef90_A6PWC8|UniRef90_Q95J06|UniRef90_Q96NU1|UniRef90_Q9BYL1|UniRef90_A0A493TFJ9|UniRef90_P00846|UniRef90_Q96NU1-2|UniRef90_A0A087WW16|UniRef90_A0A087WXB3|UniRef90_A0A087WYH2|UniRef90_A0A087WYW1|UniRef90_A0A087WV57|UniRef90_A0A087WX24|UniRef90_G3SA20|UniRef90_A0A087X1G6|UniRef90_G1SG54|UniRef90_A0A087X223|UniRef90_Q9BVV2|UniRef90_A0A087X2A3|UniRef90_A0A087WWQ4; UniRef90_O60393|UniRef90_Q9Y3T9; UniRef90_Q96M94|UniRef90_Q6TDP4|UniRef90_B4DWR6|UniRef90_J3QLT4|UniRef90_Q15109-6|UniRef90_F7ANQ0; UniRef90_Q8BM47|UniRef90_Q494U1|UniRef90_J3KSL1|UniRef90_Q494U1-2; UniRef90_P22079|UniRef90_Q5SV97; UniRef90_Q8WMB6|UniRef90_A0A2K5RL97|UniRef90_Q5TGS1|UniRef90_Q9HCC6|UniRef90_Q86VV4; UniRef90_B4E187|UniRef90_P05161|UniRef90_P04440|UniRef90_Q9H1K1; UniRef90_Q96K78|UniRef90_O00468|UniRef90_Q9BTA9|UniRef90_O00468-7|UniRef90_P18577|UniRef90_P51956,Y,,,,,N,,,,
51,UniRef50,ENSEMBLIDxref,v2.1.1,UinRef 50% sequence identity genes,"UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.",,https://www.uniprot.org/uniref/<ID>,UniRef50_P17693|UniRef50_Q8NGA8; UniRef50_Q8NGC2|UniRef50_Q6IEY1|UniRef50_Q8NC06-3; UniRef50_A0A2K6PQG9|UniRef50_A0A2U3Z6A0|UniRef50_Q95J06|UniRef50_Q96NU1|UniRef50_Q9BYL1|UniRef50_A0A493TFJ9|UniRef50_P00846|UniRef50_Q1RNF8|UniRef50_A0A2K5RHT8|UniRef50_G1PAJ8|UniRef50_A0A087WYH2|UniRef50_M3YQW4|UniRef50_A0A087WV57|UniRef50_A0A087X2A3|UniRef50_G3SA20|UniRef50_A0A087X1G6|UniRef50_Q15057|UniRef50_A0A2K5ZXK5|UniRef50_Q9BVV2|UniRef50_Q5TA76; UniRef50_O60393|UniRef50_Q9Y3T9; UniRef50_Q96M94|UniRef50_Q6TDP4|UniRef50_B4DWR6|UniRef50_J3QLT4|UniRef50_Q15109; UniRef50_Q8BM47|UniRef50_Q494U1|UniRef50_J3KSL1; UniRef50_P22079|UniRef50_Q5SV97; UniRef50_A0A2K5LIZ5|UniRef50_Q9HCC6|UniRef50_Q5TGS1|UniRef50_Q6PDH4; UniRef50_B4E187|UniRef50_P05161|UniRef50_P04440|UniRef50_Q9H1K1; UniRef50_Q96K78|UniRef50_O00468|UniRef50_Q9BTA9|UniRef50_P18577|UniRef50_P51956,Y,,,,,N,,,,
52,UniParc,ENSEMBLIDxref,v2.1.1,UniParc,The UniProt Archive (UniParc) is a comprehensive and non-redundant database that contains most of the publicly available protein sequences in the world.,,https://www.uniprot.org/uniparc/<ID>,UPI001163D9C4|UPI000D1938F0|UPI0000041E1E|UPI0000041BC1; UPI0000041D88|UPI0000041D3C|UPI000387CF9A; UPI00044374A9|UPI0007E52A82|UPI0002D212D4|UPI000155D47B|UPI000012860F|UPI0000D61E04|UPI0001B7917F|UPI000155D47A|UPI000201D341|UPI000155D479|UPI0002065210|UPI0004E4CAA9|UPI00046209A0|UPI0004E4CA1D|UPI0001AE65FD|UPI0004E4C9EB|UPI00005620B6|UPI000277615B|UPI000462093F|UPI0004E4CB24|UPI0004E4CC2E|UPI0004E4CACB|UPI00053BD5C8|UPI0004E4C86A|UPI0004E4C96E|UPI0004E4CD21; UPI00019B220C|UPI00019B220B|UPI000041820C; UPI000019832F|UPI00001DFBF0|UPI00017A8154|UPI000268AE1E|UPI000215117A|UPI0000DBE19F; UPI000166304A|UPI0000DBEE58|UPI00002377C5|UPI00001416D8|UPI000268B00E|UPI000268AE1F; UPI0000131631|UPI0001A4717E|UPI0003E30FA7; UPI0001CF2A0F|UPI0001881B51|UPI000047096C|UPI000006EC19|UPI0001D3B176|UPI0001D3BBEE; UPI0004F2367C|UPI0004F23698|UPI0000089275|UPI00053BD5BA|UPI000021CA9A|UPI000007018B|UPI0000048D70; UPI000004B6DF|UPI000387D73E|UPI001088D15F|UPI0010872C9B|UPI0010BB94D6|UPI000387B6E0|UPI0004620DA5|UPI0004E4CB7F,Y,,,,,N,,,,
53,NCBInucleotide,ENSEMBLIDxref,v2.1.1,NCBI Nucleotide,,,https://www.ncbi.nlm.nih.gov/nuccore/<ID>,LT989888|AL627309|L78442|BC136907|BC136908|AF399574|BK004223|AB065592; AB065895|AF399581|BK004526|AL732372|BC137547|BK004481|KU178780|KP290153; KJ535069|AL645608|JQ797332|AL118506|BC067362|JX093066|JX093070|JX093071|AK054643|BC024295|BC033213|AC003035|AC003037|HM852815|AC006942|AC018766|KC877749|AC005618|AC008781|KC877131|AL022342|AL031666|KF456929|KF456930|JQ703741|JQ797915|KP317047|KP317050|KY409340|AP008478|JX093093|AC242498|FP700111|AC090018|AC091633|AC126170|AL121829|AL353779; AC004534|AL050019|AL645608|BC003555; AK057298|BC015415|BC109058|BC109059|AB051464|AL834313|AY423763|AL645608|AK301650|CR812478|CR933878|BC105742|CH471183; AC083900|AC096772|BC020812|BC151137|AK123204|AL136730|AL645608|CH471183|BC101386|BC101387|AC090844|AC102799; U39573|EF579964|AY324876|AC004687|AC005962|BC107166|BC107167|M58151|KF150175|AK123855|AL645608|BC006300; HQ154163|AL645608|AL031847|AB048791|BC012351|AC008807|AC114277|KC876975; AC007878|AC096569|AC104084|AC109343|AL645608|AY375804|AY009127|AY009128|AC008119|BC011906|BC061903|U47101|M13755|M21786|AY168648|BT007297|CH471183|BC009507; AY181246|AK027360|CH471052|BC113451|AB191264|AL645608|AF016903|U84406|BC004220|BC007649|BC034009|BC063620|AL161936|AL358234|LR214928|AL139082|KF459684,Y,,,,,N,,,,
54,NCBIprotein,ENSEMBLIDxref,v2.1.1,NCBI Protein,,,https://www.ncbi.nlm.nih.gov/protein/<ID>,SPI37852.1|AAI36908.1|AAI36909.1|AAK95059.1|DAA04621.1|BAC05820.1; BAC06111.1|AAK95066.1|DAA04924.1|AAI37548.1|DAA04879.1|ALQ34238.1|ALI87340.1; AHW56708.1|AFZ93926.1|AAH67362.1|AFP36417.1|AFP36421.1|AFP36422.1|BAB70781.1|AAH24295.1|AAH33213.1|ADL30666.1|AFF86596.1|AFI51648.1|AJT36220.1|AJT36259.1|AQU30835.1|BAE10202.1|AFP36444.1; AAC12957.1|CAB43240.2|AAH03555.1; BAB71415.1|AAH15415.1|AAI09059.1|AAI09060.1|BAB21768.1|CAD38983.1|AAR03710.1|BAG63128.1|AAI05743.1|EAW56302.1; AAH20812.1|AAI51138.1|BAC85557.1|CAB66664.1|EAW56299.1|AAI01387.1|AAI01388.1; AAC50717.1|ABQ53140.1|AAP72968.1|AAI07167.1|AAI07168.1|AAA63213.1|AGQ48858.1|BAC85711.1|AAH06300.1; ADW24281.1|BAB13510.1|AAH12351.1; AAQ88063.1|AAG37427.1|AAG37428.1|AAH11906.1|AAH61903.1|AAC50885.1|AAA36038.1|AAA36128.1|AAN86983.1|AAP35961.1|EAW56295.1|AAH09507.1; AAO27358.1|BAB55061.1|EAW79818.1|AAI13452.1|BAD52440.1|AAC39776.1|AAB52917.1|AAH04220.2|AAH07649.1|AAH34009.1|AAH63620.1|VEU33313.1,Y,,,,,N,,,,
57,DIP,ENSEMBLIDxref,v2.1.1,DIP,Database of Interacting Proteins,,https://dip.doe-mbi.ucla.edu/dip/DIPview.cgi?PK=<ID>,39616; 40642; 2928; 31316; 45598; 34063; 33194; 169; 31674; 61029,N,,,,,N,,,,
58,MINT,ENSEMBLIDxref,v2.1.1,MINT,The Molecular INTeraction Database,,https://mint.bio.uniroma2.it/index.php/results-interactions/?id=<ID>,Q9H1K1; P33981; P36941; Q9Y376; Q9Y385; P51168; P23786; P84157; Q9UK58; P49406,Y,,,,,N,,,,
60,ChEMBL,ENSEMBLIDxref,v2.1.1,ChEMBL,Manually curated database of bioactive molecules with drug-like properties.,,https://www.ebi.ac.uk/chembl/target_report_card/<ID>/,CHEMBL5898; CHEMBL3983; CHEMBL1250360; CHEMBL3885534; CHEMBL2321635; CHEMBL2107836; CHEMBL3238; CHEMBL1613741; CHEMBL2176775; CHEMBL5416,Y,,,,,N,,,,
61,DrugBank,ENSEMBLIDxref,v2.1.1,DrugBank,The DrugBank database is a bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information.,,https://www.drugbank.ca/drugs/<ID>,DB01782|DB12010; DB00594|DB14509|DB00384; DB00583|DB01074; DB00168|DB02772; DB00786; DB00142|DB00130; DB00659|DB00546|DB00404|DB00543|DB11901|DB11859|DB01558|DB00237|DB00241|DB00475|DB01594|DB00349|DB01068|DB00628|DB01559|DB01189|DB00829|DB00228|DB01215|DB00402|DB00898|DB00189|DB00292|DB01567|DB01205|DB01544|DB00690|DB06716|DB01437|DB00801|DB01159|DB00753|DB00602|DB00555|DB00431|DB00186|DB01043|DB00371|DB00463|DB01028|DB01107|DB12458|DB01595|DB00842|DB00312|DB00592|DB01708|DB01588|DB00794|DB00818|DB01589|DB01236|DB09118|DB00306|DB01956|DB00231|DB11582|DB00273|DB00897; DB04522|DB12010|DB02482|DB02010|DB00675; DB00042; DB08870|DB06324,Y,,,,,N,,,,
62,BioMuta,ENSEMBLIDxref,v2.1.1,BioMuta,"A single-nucleotide variation (SNV) and disease association database where variations are mapped to genomes and RefSeq nucleotide entries, and unified through UniProtKB/Swiss-Prot positional coordinates.",,,OR4F4; OR4E2; SAMD10; NOBOX; KLHL15; PLEKHM3; LPO; HES3; ISCU; ADGRG7,Y,,,,,N,,,,
63,DMDM,ENSEMBLIDxref,v2.1.1,DMDM,,,,38372849; 38372663; 26392486; 88909167; 172046173; 12643419; 74746514; 313104118; 229462926; 160112977,Y,,,,,N,,,,
64,CPTAC,ENSEMBLIDxref,v2.1.1,CPTAC,,,,CPTAC-2234; CPTAC-1370; CPTAC-1171|CPTAC-1193; CPTAC-204|CPTAC-205; CPTAC-552; non-CPTAC-2682; CPTAC-1786; CPTAC-794|CPTAC-795; CPTAC-138|CPTAC-139; CPTAC-1313,Y,,,,,N,,,,
65,ProteomicsDB,ENSEMBLIDxref,v2.1.1,ProteomicsDB,,,,77933; 73472; 79666|12390; 49389|49390; 77318; 68476|68477|68478; 16955|53957; 65128|13941; 80422|80423; 77050,Y,,,,,N,,,,
66,DNASU,ENSEMBLIDxref,v2.1.1,DNASU,,,,26686; 135935; 389072; 23479; 84873; 93190; 7272; 608; 4055; 6908,Y,,,,,N,,,,
67,GeneID,ENSEMBLIDxref,v2.1.1,NCBI gene,,,,26682|79501; 26683|729759|81399|79777; 140700|148398; 135935|26155; 80311|339451; 389072|84069; 4025|84808; 57801|390992; 23479|9636; 84873|375790,Y,,,,,N,,,,
68,KEGG,ENSEMBLIDxref,v2.1.1,KEGG,,,https://www.genome.jp/dbget-bin/www_bget?<ID>,hsa:26682; hsa:140700; hsa:135935; hsa:80311; hsa:389072; hsa:4025; hsa:390992; hsa:23479; hsa:84873; hsa:643904,Y,,,,,N,,,,
69,EuPathDB,ENSEMBLIDxref,v2.1.1,EuPathDB,,,https://www.eupathdb.org/gene/<ID>,HostDB:ENSG00000177693.3; HostDB:ENSG00000221977.1; HostDB:ENSG00000130590.13|HostDB:ENSG00000046653.14|HostDB:ENSG00000104973.14|HostDB:ENSG00000254245.2|HostDB:ENSG00000101040.19|HostDB:ENSG00000196369.10|HostDB:ENSG00000114331.13|HostDB:ENSG00000125531.6|HostDB:ENSG00000186226.8; HostDB:ENSG00000106410.14; HostDB:ENSG00000174010.9; HostDB:ENSG00000178385.13|HostDB:ENSG00000008838.17; HostDB:ENSG00000167419.10; HostDB:ENSG00000173673.7|HostDB:ENSG00000164188.8; HostDB:ENSG00000075292.18|HostDB:ENSG00000136003.15; HostDB:ENSG00000144820.7|HostDB:ENSG00000136098.16,Y,,,,,N,,,,
71,HPA,ENSEMBLIDxref,v2.1.1,Human Protein Atlas,Human Protein Atlas,,https://www.proteinatlas.org/search/<ID>,HPA040973; HPA065730; HPA035046; HPA028688; HPA047927|HPA072697; CAB006329|HPA038602|HPA057592; HPA048916; HPA028396; CAB010166|CAB013229; CAB026202|HPA061617,Y,,,,,N,,,,
72,neXtProt,ENSEMBLIDxref,v2.1.1,neXtProt,,,https://www.nextprot.org/entry/<ID>/,NX_Q96R69; NX_Q8NGC2; NX_Q9BYL1; NX_O60393; NX_Q96M94; NX_Q6ZWE6; NX_P22079; NX_Q5TGS1; NX_Q9H1K1; NX_Q96K78,Y,,,,,N,,,,
74,eggNOG,ENSEMBLIDxref,v2.1.1,eggNOG,It is based on the original idea of COGs and expands that idea to non-supervised orthologous groups constructed from numerous organisms.,,http://eggnogdb.embl.de/#/app/results#<ID>,ENOG410J9XX|ENOG411192Y; ENOG410IVIK|ENOG410YB9C; KOG3516|ENOG410XPHG|ENOG410IJ7W|ENOG41128Z9|KOG4800|ENOG4110EPW|KOG4665|COG0356|ENOG410IHD9|ENOG410Z0HI|KOG3594|ENOG410XQHI|ENOG410ITRI|ENOG410XSDA|KOG3565|ENOG410XS44|KOG0521|COG5347|ENOG410IGYC|ENOG410YC0Q; KOG0490|ENOG410YIJ3; KOG4441|ENOG410XNX8; KOG1829|ENOG410ZMB5|ENOG410IF72|ENOG410YPDT; KOG2408|ENOG410XPZ3; ENOG410INMI|ENOG4112CPE; ENOG410IN3N|ENOG4111GCE|ENOG410IWG3|ENOG410YI0S|KOG3361|COG0822; KOG4193|ENOG410XSD2,Y,,,,,N,,,,
75,GeneTree,ENSEMBLIDxref,v2.1.1,GeneTree,,,,ENSGT00940000162706; ENSGT00390000008161|ENSGT00390000006915|ENSGT00940000160439|ENSGT00940000164906|ENSGT00940000154897|ENSGT00950000182824|ENSGT00940000156389|ENSGT00390000006008|ENSGT00950000183301; ENSGT00650000093445; ENSGT00940000159116; ENSGT00940000159743|ENSGT00390000016438; ENSGT00940000160488; ENSGT00730000111482|ENSGT00940000161387; ENSGT00940000153322|ENSGT00390000015813; ENSGT00940000159169|ENSGT00440000037780|ENSGT00940000159738; ENSGT00390000002856,Y,,,,,N,,,,
76,HOGENOM,ENSEMBLIDxref,v2.1.1,HOGENOM,Database of Complete Genome Homologous Genes Families,,,HOG000041362; HOG000132938; HOG000113810; HOG000231204|HOG000234617; HOG000090264; HOG000016084; HOG000236346|HOG000290662; HOG000069228; HOG000236310; HOG000137599,Y,,,,,N,,,,
77,KO,ENSEMBLIDxref,v2.1.1,KEGG Ontology,KEGG Ontology,,https://www.genome.jp/dbget-bin/www_bget?ko:<ID>,K04257; K10452; K12550; K09088; K22068; K08464; K08866; K05153; K03159; K08272|K03120,Y,,,,,N,,,,
78,OMA,ENSEMBLIDxref,v2.1.1,OMA,,,,LRKWDVH; AENIPCH; FCPQALG; DQNKIHL; CNMFELS; RCRDHGM; VWRPWSP; SMVTEMV; DYRQEEI; TRSFCCR,Y,,,,,N,,,,
79,OrthoDB,ENSEMBLIDxref,v2.1.1,OrthoDB,"OrthoDB presents a catalog of orthologous protein-coding genes across vertebrates, arthropods, fungi, plants, and bacteria.",,https://www.orthodb.org/?query=<ID>,958833at2759; 1010638at2759|1546859at2759; 1252828at2759; 729946at2759; 250404at2759; 177737at2759; 276568at2759; 1095795at2759; 1406557at2759; 349194at2759,Y,,,,,N,,,,
80,TreeFam,ENSEMBLIDxref,v2.1.1,TreeFam,Database of animal gene trees,,http://www.treefam.org/family/<ID>,TF337251; TF325918; TF337576; TF328485; TF317067; TF314316; TF351373; TF105422; TF351485; TF333220,Y,,,,,N,,,,
81,Reactome,ENSEMBLIDxref,v2.1.1,Reactome,,,https://reactome.org/content/detail/<ID>,R-HSA-381753; R-HSA-8941413; R-HSA-1362409; R-HSA-5669034; R-HSA-5668541|R-HSA-5676594; R-HSA-380972|R-HSA-6798695; R-HSA-9037629; R-HSA-983168; R-HSA-2672351; R-HSA-6782315,Y,,,,,N,,,,
82,ChiTaRS,ENSEMBLIDxref,v2.1.1,ChiTaRS,Database of chimeric transcripts and RNA-seq data,,,ACBD4; CNTNAP2|HLA-A|SAMD10|GPM6B|ATP6|MED25|ZMYND8|DNAH8|SRGAP2B|ACAP2; KLHL15|AGER; PLEKHM3|MED24; LPO; HLA-A; ZNF638|HLA-DPB1|ISCU; ADGRG7|WAC|RHD|NEK3; SEC24C|TTYH2|SLC38A11|HLA-B|XRN1|PPP4R1|PRR5|HLA-DRB1; TNFRSF17|SECTM1,Y,,,,,N,,,,
83,GeneWiki,ENSEMBLIDxref,v2.1.1,GeneWiki,,,,NOBOX; Lactoperoxidase; ISCU; TTK_(gene); TNFRSF17; Lymphotoxin_beta_receptor; CAB39; B3GALT5; UBE2J1; SCNN1B,Y,,,,,N,,,,
84,GenomeRNAi,ENSEMBLIDxref,v2.1.1,GenomeRNAi,,,,26682; 79777; 140700; 135935; 80311; 389072; 4025; 390992; 23479; 84873,Y,,,,,N,,,,
85,CRC64,ENSEMBLIDxref,v2.1.1,CRC64,,,,399A0675E540C86D|903D4D8E98EA07F6; 59A922BBA6978452|E3241CE48D9E9081; B4CE79C106B91FB8|C32A8E01834CB2E2|DF2678F090A3E946|7CE2E149F1BB821A|DC6D801F30E7E862|9EB7BBFA85047C9E|8A9D02F98EBA61E1|48DC72597BCEBEC9|AF7628CF46E8E4D5|6D2D9F98DEA4F3A3|50EF59FB1911CFDC|1EAACA0EC8CBAC49|3252BCA9CB0C405B; 02ED17B02018A89C; E37606E8AE367C83|7A857C0E39686356|36C93FA1BDFB557F; 53A2BCF3580CAE14|03B8544D835BD239; BC7AA410997198C0; FDB69EB6D9F3D02C|F64A0949CBB0654D|FF9F1830502644D4; 6B58A6E8CDE8C538|91F414FC4C703D26|0166D3EC9F1EEB47; D6CAAA78AC0E4679|11C008F6987D75B3|5A346304644B0BB4|CAB3F77DD187A266,Y,,,,,N,,,,
86,UniProt,ENSEMBLIDxref,v2.1.1,UniProt,"UniProt is a freely accessible database of protein sequence and functional information, many entries being derived from genome sequencing projects.",,https://www.uniprot.org/uniprot/<ID>,A0A2U3U0J3|Q8NH21; Q6IEY1|A0A126GV92; A6PWC8|Q5SV95|Q96NU1|H7BY14|H7C3J6|A0A087WXB3|A0A087WYW1|A0A087WX24|I7G285|A0A087X1J5|A0A087X223|A0A087X2A3|A0A087WYU3; Q9Y3T9; Q6TDP4|J3QLT4|Q0VGE6; Q494U1|Q494U1|Q494U1|J3KSM5; Q5SV97|Q5SV97; E9PB28|Q9HCC6|D6REB3; A0A096LPJ4|A0A096LNZ9|P05161; O00468|A0A494C0G5|A0A494C1I6|A0A087X208,Y,,,,,N,,,,
87,GO,ENSEMBLIDxref,v2.1.1,Gene Ontology,Gene Ontology,,https://www.ebi.ac.uk/QuickGO/term/<ID>,GO:0016021|GO:0005886|GO:0004930|GO:0004984|GO:0007186; GO:0003677|GO:0005634; GO:0005829|GO:0030690|GO:0030691|GO:0005730|GO:0005654|GO:0005634|GO:0003682|GO:0042393|GO:0031491|GO:0070491|GO:0003723|GO:0003714|GO:0006915|GO:0034644|GO:0031497|GO:0002903|GO:0035067|GO:2001243|GO:0000122|GO:1901796|GO:0042273; GO:0015629|GO:0030054|GO:0032839|GO:0005615|GO:0043025|GO:0014069|GO:0045211|GO:0051015|GO:0060090|GO:0031208|GO:0030036|GO:0007420|GO:0016567; GO:0005856|GO:0031966|GO:0005739|GO:0005886|GO:1901612|GO:0070300|GO:1901981|GO:0001786|GO:0061158|GO:0043065|GO:0001666; GO:0005737|GO:0005634|GO:0006355|GO:0014850; GO:0005634|GO:0003677|GO:0046983|GO:0006355|GO:0000790|GO:0000981|GO:0001227|GO:0070888|GO:0071820|GO:0000977|GO:0008134|GO:0009952|GO:0030154|GO:0045665|GO:0000122; GO:0005737|GO:0005829|GO:0005576|GO:0005654|GO:0005634|GO:0005178|GO:0031386|GO:0031625|GO:0042742|GO:0051607|GO:0007229|GO:0072643|GO:0072608|GO:0032020|GO:0019941|GO:0031397|GO:0032480|GO:0045071|GO:0030501|GO:0045648|GO:0032649|GO:0034340|GO:0019985|GO:0060337|GO:0016032; GO:0005604|GO:0030054|GO:0062023|GO:0005829|GO:0070062|GO:0005576|GO:0005796|GO:0016021|GO:0043202|GO:0005886|GO:0045202|GO:0005509|GO:0035374|GO:0002162|GO:0043395|GO:0043236|GO:0033691|GO:0005200|GO:0009887|GO:0045162|GO:0016358|GO:0030198|GO:0007213|GO:0006024|GO:0006027|GO:0008045|GO:0007528|GO:0051491|GO:0043547|GO:0045887|GO:0045944|GO:0043113|GO:0001523|GO:0007165|GO:0050808|GO:0009888; GO:0016021|GO:0046872,Y,,,,,N,,,,
88,PIR,ENSEMBLIDxref,v2.1.1,PIR,,,,A28304; I37552; I39196; A38282|B54024|E54024|F54024|H54024|T09568; B54024|E54024|F54024|H54024; A24853; JN0877; S06053; T00334; T00364,Y,,,,,N,,,,
89,Gene_Synonym,ENSEMBLIDxref,v2.1.1,Gene_Synonym,,,,C20orf136|ATP6; KIAA1677; DAPR|PLEKHM1L; SAPX; BHLHB43; NIFUN; GPR128; MPS1|MPS1L1; BCM|BCMA; D12S370|TNFCR|TNFR3|TNFRSF3,Y,,,,,N,,,,
90,ComplexPortal,ENSEMBLIDxref,v2.1.1,ComplexPortal,"The Complex Portal is a manually curated, encyclopaedic resource of macromolecular complexes from a number of key model organisms.",,https://www.ebi.ac.uk/complexportal/complex/<ID>,CPX-2188|CPX-312|CPX-313; CPX-341|CPX-344|CPX-346|CPX-348; CPX-419; CPX-341|CPX-343|CPX-344|CPX-347; CPX-2164|CPX-2166|CPX-2167|CPX-2168|CPX-2174|CPX-2951|CPX-2954; CPX-1195; CPX-880|CPX-922; CPX-696; CPX-3219|CPX-3220; CPX-1004|CPX-900|CPX-903|CPX-989|CPX-997,Y,,,,,N,,,,
91,TCDB,ENSEMBLIDxref,v2.1.1,TCDB,Functional and Phylogenetic Classification of Membrane Transport Proteins,,http://www.tcdb.org/search/result.php?tc=<ID>,1.A.6.1.1; 9.A.14.7.4; 2.A.7.9.9; 1.A.9.5.4; 8.A.5.1.1; 1.A.47.1.1; 1.F.1.1.1; 2.A.1.44.3; 9.B.82.1.2; 2.A.1.1.88,Y,,,,,N,,,,
92,BioCyc,ENSEMBLIDxref,v2.1.1,BioCyc,"BioCyc is a collection of 17043 Pathway/Genome Databases (PGDBs), plus software tools for exploring them.",,https://biocyc.org/getid?id=<ID>,MetaCyc:MONOMER-20081; MetaCyc:HS08187-MONOMER; MetaCyc:HS10587-MONOMER; MetaCyc:HS11014-MONOMER; MetaCyc:HS04372-MONOMER; MetaCyc:ENSG00000168288-MONOMER; MetaCyc:HS08467-MONOMER; MetaCyc:HS00644-MONOMER; MetaCyc:HS05981-MONOMER; MetaCyc:HS04051-MONOMER,N,,,,,N,,,,
94,SwissLipids,ENSEMBLIDxref,v2.1.1,SwissLipids,,,,SLP:000000792|SLP:000000844; SLP:000001044; SLP:000001931; SLP:000000940; SLP:000001071; SLP:000001526; SLP:000001553; SLP:000000652; SLP:000000140; SLP:000001082,Y,,,,,N,,,,
95,UniPathway,ENSEMBLIDxref,v2.1.1,UniPathway,UniPathway,,https://www.nextprot.org/term/<ID>/,UPA00143; UPA00378; UPA00659; UPA00253|UPA00705; UPA00241|UPA00705; UPA00705; UPA00109; UPA00115; UPA00220; UPA00534,Y,,,,,N,,,,
96,Gene_ORFName,ENSEMBLIDxref,v2.1.1,Gene_ORFName,,,,hCG_19035; CGI-66|hCG_2029691|hCG_20419; CGI-76|HSPC153|HSPC205|hCG_15053; hCG_1645842|hCG_16055; BM-001|UNQ530/PRO1073; hCG_27621; hCG_33132; PSEC0038; hCG_1992246; hCG_23298,Y,,,,,N,,,,
97,GlyConnect,ENSEMBLIDxref,v2.1.1,GlyConnect,,,,1855; 795; 1981; 1488; 1919; 773; 1525; 1224; 625; 1608,Y,,,,,N,,,,
98,DisProt,ENSEMBLIDxref,v2.1.1,DisProt,,,,DP00443; DP00173; DP00090; DP00069; DP01450; DP00492; DP01131; DP00321; DP01518; DP01420,Y,,,,,N,,,,
99,GuidetoPHARMACOLOGY,ENSEMBLIDxref,v2.1.1,GuidetoPHARMACOLOGY,,,,2264; 739; 2720; 412; 1488; 1877; 624; 2154; 1232; 628,N,,,,,N,,,,
100,MEROPS,ENSEMBLIDxref,v2.1.1,MEROPS,,,,P02.020; M10.026; I39.006; S01.132; S01.152; S01.155; C14.009; A28.003; M16.974; C85.004,Y,,,,,N,,,,
101,ESTHER,ENSEMBLIDxref,v2.1.1,ESTHER,,,,human-ABHD6; human-AADACL3; human-AADACL2; human-ABHD18; human-SERAC1; human-LYPLA1; human-NDRG4; human-PLA2G15; human-EPHX1; human-PRCP,Y,,,,,N,,,,
102,Allergome,ENSEMBLIDxref,v2.1.1,Allergome,,,,11040; 2121; 1064; 9614; 8213; 11858; 8363; 3322|411; 9621; 11697,Y,,,,,N,,,,
103,PeroxiBase,ENSEMBLIDxref,v2.1.1,PeroxiBase,,,,3316; 3605; 4448; 3320; 5398|5827; 4426; 3355; 3606; 3601; 3604|3629,Y,,,,,N,,,,
104,REBASE,ENSEMBLIDxref,v2.1.1,REBASE,,,,1161|4240; 12076; 4636; 4119; 4120,Y,,,,,N,,,,
105,PATRIC,ENSEMBLIDxref,v2.1.1,PATRIC,"PATRIC, the Pathosystems Resource Integration Center, provides integrated data and analysis tools to support biomedical research on bacterial infectious diseases.",,"https://www.patricbrc.org/search/?keyword(""<ID>"")",fig|1028802.3.peg.20; fig|1028802.3.peg.1826,Y,,,,,N,,,,
106,Pathway(BioCarta)_short,dbNSFP,4.0c,BioCarta,Short name of the Pathway(s) the gene belongs to (from BioCarta),,http://amp.pharm.mssm.edu/Harmonizome/search?t=geneSet&q=<ID>,ox40Pathway; agrPathway;alkPathway;gsk3Pathway;pitx2Pathway;ps1Pathway;hesPathway;wntPathway; acrPathway; HivnefPathway; gsPathway;CSKPathway;sppaPathway;agpcrPathway;biopeptidesPathway;CCR3Pathway;gcrPathway;cxcr4Pathway;erkPathway;fMLPpathway;tubbyPathway;mPRPathway;raccPathway;edg1Pathway;myosinPathway;gpcrPathway;bArrestinPathway;Par1Pathway; ptdinsPathway; myosinPathway;Par1Pathway; atmPathway; DNAfragmentPathway;caspasePathway;fasPathway;setPathway;HivnefPathway;deathPathway;mitochondriaPathway;tnfr1Pathway; deathPathway,N,,,,,N,,,,
107,Pathway(BioCarta)_full,dbNSFP,4.0c,BioCarta pathway,Full name(s) of the Pathway(s) the gene belongs to (from BioCarta),,,"OX40 Signaling Pathway; Agrin in Postsynaptic Differentiation;ALK in cardiac myocytes;Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages;Multi-step Regulation of Transcription by Pitx2;Presenilin action in Notch and Wnt signaling;Segmentation Clock;WNT Signaling Pathway; Ahr Signal Transduction Pathway; HIV-I Nef: negative effector of Fas and TNF; Activation of cAMP-dependent protein kinase, PKA;Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor;Aspirin Blocks Signaling Pathway Involved in Platelet Activation;Attenuation of GPCR Signaling;Bioactive Peptide Induced Signaling Pathway;CCR3 signaling in Eosinophils;Corticosteroids and cardioprotection;CXCR4 Signaling Pathway;Erk1/Erk2 Mapk Signaling pathway;fMLP induced chemokine gene expression in HMC-1 cells;G-Protein Signaling Through Tubby Proteins;How Progesterone Initiates Oocyte Membrane;Ion Channels and Their Functional Role in Vascular Endothelium;Phospholipids as signalling intermediaries;PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Signaling Pathway from G-Protein Families;b-arrestins in GPCR Desensitization;Thrombin signaling and protease-activated receptors; Phosphoinositides and their downstream targets.; PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Thrombin signaling and protease-activated receptors; ATM Signaling Pathway; Apoptotic DNA fragmentation and tissue homeostasis;Caspase Cascade in Apoptosis;FAS signaling pathway ( CD95 );Granzyme A mediated Apoptosis Pathway;HIV-I Nef: negative effector of Fas and TNF;Induction of apoptosis through DR3 and DR4/5 Death Receptors ;Role of Mitochondria in Apoptotic Signaling;TNFR1 Signaling Pathway; Induction of apoptosis through DR3 and DR4/5 Death Receptors",N,,,,,N,,,,
108,Pathway(ConsensusPathDB),dbNSFP,4.0c,Pathway(ConsensusPathDB),Pathway(s) the gene belongs to (from ConsensusPathDB),,,Olfactory transduction - Homo sapiens (human);Olfactory receptor activity;Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;GPCR downstream signalling; Olfactory transduction - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;GPCR downstream signalling; Oxidative phosphorylation; Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Validated transcriptional targets of TAp63 isoforms;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53; EGFR1; Mitochondrial biogenesis; Human papillomavirus infection - Homo sapiens (human); RIG-I-like receptor signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);RIG-I-like Receptor Signaling;Type II interferon signaling (IFNG);DNA Repair;Cytokine Signaling in Immune system;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;Negative regulators of DDX58/IFIH1 signaling;Termination of translesion DNA synthesis;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass;Interferon alpha/beta signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling; ECM-receptor interaction - Homo sapiens (human);Primary Focal Segmental Glomerulosclerosis FSGS;Splicing factor NOVA regulated synaptic proteins;Developmental Biology;Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Heparan sulfate/heparin (HS-GAG) metabolism;Integrin cell surface interactions;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Extracellular matrix organization;Metabolism;Metabolism of vitamins and cofactors;Integrin;role of nicotinic acetylcholine receptors in the regulation of apoptosis;agrin in postsynaptic differentiation;NCAM signaling for neurite out-growth;Retinoid metabolism and transport;NCAM1 interactions;Non-integrin membrane-ECM interactions;G alpha (i) signalling events;Axon guidance;Visual phototransduction;ECM proteoglycans;GPCR downstream signalling;Wnt Canonical;Wnt Mammals; MicroRNAs in cancer - Homo sapiens (human);miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miRNA targets in ECM and membrane receptors,N,,,,,N,,,,
111,Function_description,dbNSFP,4.0c,Function description,Function description of the gene (from Uniprot),,,"FUNCTION: Odorant receptor. {ECO:0000305}.; FUNCTION: May play a role in photoreceptor development. {ECO:0000250}.; FUNCTION: Acts as an inhibitor of histone acetyltransferase activity; prevents acetylation of all core histones by the EP300/p300 histone acetyltransferase at p53/TP53-regulated target promoters in a histone deacetylases (HDAC)-independent manner. Acts as a transcription corepressor of p53/TP53- and TP63-mediated transactivation of the p21/CDKN1A promoter. Involved in the regulation of p53/TP53-dependent apoptosis. Associates together with TP63 isoform TA*-gamma to the p21/CDKN1A promoter. {ECO:0000269|PubMed:16322561, ECO:0000269|PubMed:20123734, ECO:0000269|PubMed:20959462}.; FUNCTION: Substrate-recognition component of some cullin-RING- based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(KLHL17) mediates the ubiquitination and subsequenct degradation of GLUR6. May play a role in the actin-based neuronal function (By similarity). {ECO:0000250}.; FUNCTION: Controls the stability of the leptin mRNA harboring an AU-rich element (ARE) in its 3' UTR, in cooperation with the RNA stabilizer ELAVL1 (PubMed:29180010). Decreases the stability of the leptin mRNA by antagonizing the function of ELAVL1 by inducing its atypical recruitment from the nucleus to the cytosol (By similarity). Binds to cardiolipin (CL), phosphatidic acid (PA), phosphatidylinositol 4-phosphate (PtdIns(4)P) and phosphatidylserine (PS) (PubMed:18191643). Promotes apoptosis by enhancing BAX-BAK hetro-oligomerization via interaction with BID in colon cancer cells (PubMed:29531808) (By similarity). {ECO:0000250|UniProtKB:Q8C886, ECO:0000269|PubMed:18191643, ECO:0000269|PubMed:29180010, ECO:0000269|PubMed:29531808}.; FUNCTION: Regulates the expression of selective PPARGC1A/B and ESRRA/B/G target genes with roles in glucose and lipid metabolism, energy transfer, contractile function, muscle mitochondrial biogenesis and oxidative capacity. Required for the efficient induction of MT-CO2, MT-CO3, COX4I1, TFB1M, TFB2M, POLRMT and SIRT3 by PPARGC1A. Positively regulates the PPARGC1A/ESRRG-induced expression of CKMT2, TNNI3 and SLC2A4 and negatively regulates the PPARGC1A/ESRRG-induced expression of PDK4. {ECO:0000250|UniProtKB:Q149B8}.; FUNCTION: Transcriptional repressor. Binds DNA on N-box motifs: 5'-CACNAG-3' (By similarity). {ECO:0000250}.; FUNCTION: Ubiquitin-like protein which plays a key role in the innate immune response to viral infection either via its conjugation to a target protein (ISGylation) or via its action as a free or unconjugated protein. ISGylation involves a cascade of enzymatic reactions involving E1, E2, and E3 enzymes which catalyze the conjugation of ISG15 to a lysine residue in the target protein. Its target proteins include IFIT1, MX1/MxA, PPM1B, UBE2L6, UBA7, CHMP5, CHMP2A, CHMP4B and CHMP6. Can also isgylate: EIF2AK2/PKR which results in its activation, DDX58/RIG-I which inhibits its function in antiviral signaling response, EIF4E2 which enhances its cap structure-binding activity and translation- inhibition activity, UBE2N and UBE2E1 which negatively regulates their activity, IRF3 which inhibits its ubiquitination and degradation and FLNB which prevents its ability to interact with the upstream activators of the JNK cascade therby inhibiting IFNA- induced JNK signaling. Exhibits antiviral activity towards both DNA and RNA viruses, including influenza A, HIV-1 and Ebola virus. Restricts HIV-1 and ebola virus via disruption of viral budding. Inhibits the ubiquitination of HIV-1 Gag and host TSG101 and disrupts their interaction, thereby preventing assembly and release of virions from infected cells. Inhibits Ebola virus budding mediated by the VP40 protein by disrupting ubiquitin ligase activity of NEDD4 and its ability to ubiquitinate VP40. ISGylates influenza A virus NS1 protein which causes a loss of function of the protein and the inhibition of virus replication. The secreted form of ISG15 can: induce natural killer cell proliferation, act as a chemotactic factor for neutrophils and act as a IFN-gamma-inducing cytokine playing an essential role in antimycobacterial immunity. {ECO:0000269|PubMed:1373138, ECO:0000269|PubMed:16009940, ECO:0000269|PubMed:16112642, ECO:0000269|PubMed:16428300, ECO:0000269|PubMed:16434471, ECO:0000269|PubMed:16872604, ECO:0000269|PubMed:18305167, ECO:0000269|PubMed:19270716, ECO:0000269|PubMed:19357168, ECO:0000269|PubMed:2005397, ECO:0000269|PubMed:20133869, ECO:0000269|PubMed:20308324, ECO:0000269|PubMed:20639253, ECO:0000269|PubMed:21543490, ECO:0000269|PubMed:22693631, ECO:0000269|PubMed:22859821, ECO:0000269|PubMed:23229543, ECO:0000269|PubMed:7526157, ECO:0000269|PubMed:8550581}.; FUNCTION: Isoform 1: heparan sulfate basal lamina glycoprotein that plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ) and directs key events in postsynaptic differentiation. Component of the AGRN-LRP4 receptor complex that induces the phosphorylation and activation of MUSK. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Calcium ions are required for maximal AChR clustering. AGRN function in neurons is highly regulated by alternative splicing, glycan binding and proteolytic processing. Modulates calcium ion homeostasis in neurons, specifically by inducing an increase in cytoplasmic calcium ions. Functions differentially in the central nervous system (CNS) by inhibiting the alpha(3)- subtype of Na+/K+-ATPase and evoking depolarization at CNS synapses. This secreted isoform forms a bridge, after release from motor neurons, to basal lamina through binding laminin via the NtA domain.; FUNCTION: Isoform 1, isoform 4 and isoform 5: neuron-specific (z+) isoforms that contain C-terminal insertions of 8-19 AA are potent activators of AChR clustering. Isoform 5, agrin (z+8), containing the 8-AA insert, forms a receptor complex in myotubules containing the neuronal AGRN, the muscle-specific kinase MUSK and LRP4, a member of the LDL receptor family. The splicing factors, NOVA1 and NOVA2, regulate AGRN splicing and production of the 'z' isoforms.; FUNCTION: Agrin N-terminal 110 kDa subunit: is involved in regulation of neurite outgrowth probably due to the presence of the glycosaminoglcan (GAG) side chains of heparan and chondroitin sulfate attached to the Ser/Thr- and Gly/Ser-rich regions. Also involved in modulation of growth factor signaling (By similarity). {ECO:0000250, ECO:0000269|PubMed:19631309, ECO:0000269|PubMed:21969364}.; FUNCTION: Inactive polyglycylase. {ECO:0000269|PubMed:19524510}.",Y,,,,,N,,,,
112,Disease_description,dbNSFP,4.0c,Disease description,Disease(s) the gene caused or associated with (from Uniprot),,,"DISEASE: Immunodeficiency 38, with basal ganglia calcification (IMD38) [MIM:616126]: A primary immunodeficiency predisposing individuals to severe clinical disease upon infection with weakly virulent mycobacteria, including Mycobacterium bovis Bacille Calmette-Guerin (BCG) vaccines. Patients are also susceptible to Salmonella and Mycobacterium tubercolosis infections. Affected individuals have intracranial calcification. {ECO:0000269|PubMed:22859821}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness. CMS8 is an autosomal recessive disease characterized by prominent defects of both the pre- and postsynaptic regions. Affected individuals have onset of muscle weakness in early childhood; the severity of the weakness and muscles affected is variable. {ECO:0000269|PubMed:19631309, ECO:0000269|PubMed:22205389, ECO:0000269|PubMed:24951643}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 16 (IMD16) [MIM:615593]: An autosomal recessive primary immunodeficiency associated with classic Kaposi sarcoma of childhood and poor T-cell recall immune responses due to complete functional OX40 deficiency. {ECO:0000269|PubMed:23897980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]: A bone disease characterized by vertebral abnormalities and ligamentous laxity that result in spinal misalignment and progressive severe kyphoscoliosis, thoracic asymmetry, and respiratory compromise resulting in early death. Additional skeletal features include elbow deformities with radial head dislocation, dislocated hips, clubfeet, and tapered fingers with spatulate distal phalanges. Many affected children have an oval face, flat midface, prominent eyes with blue sclerae, and a long philtrum. Palatal abnormalities and congenital heart disease are also observed. {ECO:0000269|PubMed:23664117, ECO:0000269|PubMed:23664118}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Robinow syndrome, autosomal dominant 2 (DRS2) [MIM:616331]: A rare skeletal dysplasia syndrome characterized by dysmorphic features resembling a fetal face, mesomelic limb shortening, hypoplastic external genitalia in males, costovertebral segmentation defects, and renal anomalies. {ECO:0000269|PubMed:25817014, ECO:0000269|PubMed:25817016}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Harel-Yoon syndrome (HAYOS) [MIM:617183]: A syndrome characterized by global developmental delay, hypotonia, intellectual disability, and axonal neuropathy. Some patients have optic atrophy and hypertrophic cardiomyopathy. HAYOS inheritance can be autosomal dominant or autosomal recessive. {ECO:0000269|PubMed:27640307}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinocerebellar ataxia 21 (SCA21) [MIM:607454]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA21 is characterized by onset in the first decades of life of slowly progressive relatively mild cerebellar ataxia associated with slight extrapyramidal features predominant in older patients and cognitive impairment predominant in younger patients. {ECO:0000269|PubMed:25070513, ECO:0000269|PubMed:29053796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD42 patients manifest global developmental delay commonly accompanied by hypotonia, seizures of various types, ophthalmological manifestations, and poor growth. {ECO:0000269|PubMed:25485910, ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284, ECO:0000269|PubMed:28087732}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Generalized epilepsy with febrile seizures plus 5 (GEFS+5) [MIM:613060]: A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity. {ECO:0000269|PubMed:15115768}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, idiopathic generalized 10 (EIG10) [MIM:613060]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Juvenile myoclonic epilepsy 7 (EJM7) [MIM:613060]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]: A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, mental retardation, developmental delay and learning disabilities. {ECO:0000269|PubMed:23023332, ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24357594, ECO:0000269|PubMed:24736733}. Note=The disease is caused by mutations affecting the gene represented in this entry.",Y,,,,,N,,,,
113,MIM_phenotype_id,dbNSFP,4.0c,MIM Phenotype ID,MIM id(s) of the phenotype the gene caused or associated with (from Uniprot),,https://www.omim.org/entry/<ID>,616126; 615120; 615593; 271640|615349; 616331; 617183; 607454; 616973; 613060; 182212,Y,,,,,N,,,,
114,MIM_disease,dbNSFP,4.0c,MIM Disease,MIM disease name(s) with MIM id(s) in '[]' (from Uniprot),,,"[MIM:616126]Immunodeficiency 38, with basal ganglia calcification; [MIM:615120]Myasthenic syndrome, congenital, 8 [recessive?]; [MIM:615593]Immunodeficiency 16 [recessive?]; [MIM:271640]Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures; [MIM:616331]Robinow syndrome, autosomal dominant 2 [dominant?]; [MIM:617183]Harel-Yoon syndrome [dominant?] [recessive?]; [MIM:607454]Spinocerebellar ataxia 21; [MIM:616973]Mental retardation, autosomal dominant 42 [dominant?]; [MIM:613060]Generalized epilepsy with febrile seizures plus 5 [dominant?];[MIM:613060]Epilepsy, idiopathic generalized 10;[MIM:613060]Juvenile myoclonic epilepsy 7; [MIM:182212]Shprintzen-Goldberg craniosynostosis syndrome",N,,,,,N,,,,
115,Orphanet_disorder_id,dbNSFP,4.0c,Orphanet Disorder ID,Orphanet Number of the disorder the gene caused or associated with,,https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=<ID>,319563; 98914|98913; 1872; 431149; 75496|93359; 3107; 963|2965|314777|314786|314790; 496790; 98773; 54260,Y,,,,,N,,,,
116,Orphanet_disorder,dbNSFP,4.0c,Orphanet Disorder,Disorder name from Orphanet,,,"Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency; Presynaptic congenital myasthenic syndromes|Postsynaptic congenital myasthenic syndromes; Cone rod dystrophy; Combined immunodeficiency due to OX40 deficiency; Ehlers-Danlos syndrome, progeroid type|Spondyloepimetaphyseal dysplasia with joint laxity; Autosomal dominant Robinow syndrome; Acromegaly|Prolactinoma|Familial isolated pituitary adenoma|Silent pituitary adenoma|Null pituitary adenoma; Optic atrophy-peripheral neuropathy-developmental delay syndrome; Spinocerebellar ataxia type 21; Left ventricular noncompaction",Y,,,,,N,,,,
117,Orphanet_association_type,dbNSFP,4.0c,Orphanet association type,the type of association beteen the gene and the disorder,,,Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) in|Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) (loss of function) in; Disease-causing germline mutation(s) (loss of function) in|Disease-causing germline mutation(s) (loss of function) in; Major susceptibility factor in|Major susceptibility factor in|Disease-causing germline mutation(s) in|Major susceptibility factor in|Major susceptibility factor in; Major susceptibility factor in; Major susceptibility factor in|Role in the phenotype of|Candidate gene tested in; Role in the phenotype of|Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) in|Disease-causing germline mutation(s) in|Disease-causing germline mutation(s) in|Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) in|Role in the phenotype of|Disease-causing germline mutation(s) in,Y,,,,,N,,,,
120,GO_biological_process,dbNSFP,4.0c,GO biological process,GO terms for biological process,,,"G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of smell; negative regulation of transcription by RNA polymerase II|negative regulation of B cell apoptotic process|apoptotic process|chromatin assembly|cellular response to UV|negative regulation of histone acetylation|ribosomal large subunit biogenesis|regulation of signal transduction by p53 class mediator|negative regulation of intrinsic apoptotic signaling pathway; brain development|protein ubiquitination|actin cytoskeleton organization; response to hypoxia|positive regulation of apoptotic process|3'-UTR-mediated mRNA destabilization; regulation of transcription, DNA-templated|response to muscle activity; negative regulation of transcription by RNA polymerase II|somitogenesis|Notch signaling pathway|cell differentiation|regulation of neurogenesis; viral process|modification-dependent protein catabolic process|translesion synthesis|positive regulation of bone mineralization|negative regulation of protein ubiquitination|ISG15-protein conjugation|negative regulation of type I interferon production|regulation of interferon-gamma production|response to type I interferon|defense response to bacterium|negative regulation of viral genome replication|positive regulation of erythrocyte differentiation|defense response to virus|type I interferon signaling pathway; retinoid metabolic process|glycosaminoglycan biosynthetic process|glycosaminoglycan catabolic process|cytoskeleton organization|signal transduction|G protein-coupled acetylcholine receptor signaling pathway|extracellular matrix organization|receptor clustering|positive regulation of GTPase activity|clustering of voltage-gated sodium channels|positive regulation of synaptic growth at neuromuscular junction|positive regulation of transcription by RNA polymerase II|synapse organization|positive regulation of filopodium assembly; protein polyglycylation; positive regulation of leukocyte migration|apoptotic process|signal transduction|tumor necrosis factor-mediated signaling pathway|positive regulation of tyrosine phosphorylation of STAT protein|negative regulation of apoptotic process|regulation of regulatory T cell differentiation|positive regulation of cell adhesion",Y,,,,,N,,,,
121,GO_cellular_component,dbNSFP,4.0c,GO cellular component,GO terms for cellular component,,,plasma membrane|integral component of membrane; nucleus; nucleus|nucleoplasm|nucleolus|cytosol|Noc1p-Noc2p complex|Noc2p-Noc3p complex; extracellular space|postsynaptic density|actin cytoskeleton|cell junction|dendrite cytoplasm|neuronal cell body|postsynaptic membrane; mitochondrion|cytoskeleton|plasma membrane|mitochondrial membrane; nucleus|cytoplasm; extracellular region|nucleoplasm|cytosol; extracellular region|basement membrane|Golgi lumen|cytosol|plasma membrane|integral component of membrane|cell junction|lysosomal lumen|synapse|collagen-containing extracellular matrix|extracellular exosome; integral component of membrane; cytosol,Y,,,,,N,,,,
122,GO_molecular_function,dbNSFP,4.0c,GO molecular function,GO terms for molecular function,,,"G protein-coupled receptor activity|olfactory receptor activity; chromatin binding|transcription corepressor activity|RNA binding|protein binding|nucleosome binding|histone binding|repressing transcription factor binding; POZ domain binding|protein-containing complex scaffold activity|actin filament binding; phosphatidylserine binding|protein binding|phosphatidic acid binding|cardiolipin binding|phosphatidylinositol phosphate binding; RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity, RNA polymerase II-specific|transcription corepressor activity|transcription factor binding|sequence-specific DNA binding|protein dimerization activity|sequence-specific double-stranded DNA binding; protein binding|protein tag; dystroglycan binding|structural constituent of cytoskeleton|extracellular matrix structural constituent|calcium ion binding|protein binding|sialic acid binding|chondroitin sulfate binding|laminin binding|heparan sulfate proteoglycan binding; metal ion binding; protein binding|ATP binding|protein-glycine ligase activity; tumor necrosis factor-activated receptor activity|protein binding",Y,,,,,N,,,,
123,Tissue_specificity(Uniprot),dbNSFP,4.0c,Tissue specificity,Tissue specificity description from Uniprot,,,"Ubiquitous (PubMed:18191643). Epressed in several cancer cell lines of differing origin (PubMed:29531808). {ECO:0000269%7CPubMed:18191643, ECO:0000269%7CPubMed:29531808}.; Muscle-specific expression is increased by endurance exercise. {ECO:0000269%7CPubMed:23836911}.; Detected in lymphoid cells, striated and smooth muscle, several epithelia and neurons. Expressed in neutrophils, monocytes and lymphocytes. Enhanced expression seen in pancreatic adenocarcinoma, endometrial cancer, and bladder cancer, as compared to non-cancerous tissue. In bladder cancer, the increase in expression exhibits a striking positive correlation with more advanced stages of the disease. {ECO:0000269%7CPubMed:22859821, ECO:0000269%7CPubMed:7490683}.; Expressed in basement membranes of lung and kidney. Muscle- and neuron-specific isoforms are found. Isoforms (y+) with the 4 AA insert and (z+8) isoforms with the 8 AA insert are all neuron-specific. Isoforms (z+11) are found in both neuronal and non-neuronal tissues. {ECO:0000269%7CPubMed:16487930, ECO:0000269%7CPubMed:20551380, ECO:0000269%7CPubMed:9652404}.; Expressed in lymph node, peripheral blood leukocytes and weakly in spleen.; Ubiquitous. Isoform 5 is expressed in pancreas. {ECO:0000269%7CPubMed:17442889}.; Ubiquitous. {ECO:0000269%7CPubMed:11551958}.; Predominantly expressed by adipose tissues. {ECO:0000269%7CPubMed:22275362}.; Ubiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes. {ECO:0000269%7CPubMed:23863933}.; Ubiquitously expressed and especially highly expressed in heart, skeletal muscle and testis.",Y,,,,,N,,,,
124,Expression(egenetics),dbNSFP,4.0c,Expression from egenetics data,Tissues/organs the gene expressed in (egenetics data from BioMart),,,skeletal muscle|heart; bone|testis|unclassifiable (Anatomical System); developmental|cochlea|thymus|epididymis|skin|stomach|testis|lens|lymphoreticular|unclassifiable (Anatomical System)|choroid|kidney|larynx|uterus|retina|pancreas|muscle|head and neck|mammary gland|islets of Langerhans|visual apparatus|cervix|fovea centralis|liver|endometrium|bone|germinal center|brain|blood|heart|lung|salivary gland|ovary|macula lutea|lymph node|oesophagus|colon|placenta|prostate|optic nerve|gum; choroid|larynx|epididymis|colon|head and neck|stomach|prostate|testis|unclassifiable (Anatomical System); fovea centralis|cartilage|endometrium|skin|stomach|bone|germinal center|testis|lens|unclassifiable (Anatomical System)|cerebellum|lung|salivary gland|choroid|retina|macula lutea|colon|head and neck|hypopharynx|mammary gland|optic nerve; endometrium|unclassifiable (Anatomical System); endometrium|bone|lacrimal gland|testis|brain|unclassifiable (Anatomical System)|heart|lung|kidney|colon|prostate|skeletal muscle|breast|islets of Langerhans; kidney|lymph node|oesophagus|blood|unclassifiable (Anatomical System); thymus|spinal ganglion|alveolus|ganglion|skin|stomach|testis|lens|unclassifiable (Anatomical System)|choroid|kidney|uterus|whole body|retina|pancreas|muscle|urinary|mammary gland|trophoblast|islets of Langerhans|visual apparatus|cervix|fovea centralis|iris|spleen|liver|peripheral nerve|cartilage|endometrium|bone|germinal center|parathyroid|brain|blood|heart|bone marrow|lung|salivary gland|ovary|macula lutea|lymph node|oesophagus|colon|placenta|prostate|aorta|optic nerve|medulla oblongata; cochlea|stomach|lacrimal gland|testis|pineal gland|choroid|larynx|kidney|uterus|whole body|pancreas|bile duct|islets of Langerhans|visual apparatus|fovea centralis|iris|spleen|liver|germinal center|heart|lung|placenta|optic nerve|epididymis|alveolus|spinal ganglion|skin|smooth muscle|lens|unclassifiable (Anatomical System)|lymphoreticular|retina|muscle|head and neck|mammary gland|tonsil|cervix|hippocampus|cartilage|endometrium|bone|parathyroid|brain|blood|bone marrow|ovary|macula lutea|colon|prostate|breast|medulla oblongata,Y,,,,,N,,,,
125,Expression(GNF/Atlas),dbNSFP,4.0c,Expression from GNF/Atlas data,Tissues/organs the gene expressed in (GNF/Atlas data from BioMart),,,ciliary ganglion|pons|subthalamic nucleus|dorsal root ganglion|atrioventricular node|superior cervical ganglion|trigeminal ganglion|globus pallidus; atrioventricular node|superior cervical ganglion; superior cervical ganglion|trigeminal ganglion; thyroid|liver|placenta|prostate|testis; ciliary ganglion|testis - interstitial|dorsal root ganglion|superior cervical ganglion|testis; pons|temporal lobe|superior cervical ganglion|trigeminal ganglion|medulla oblongata; ciliary ganglion|pons|occipital lobe|subthalamic nucleus|dorsal root ganglion|superior cervical ganglion|atrioventricular node|trigeminal ganglion; prefrontal cortex|skeletal muscle; ciliary ganglion|dorsal root ganglion|adipose tissue|atrioventricular node|trigeminal ganglion|superior cervical ganglion|skeletal muscle; liver|testis - seminiferous tubule|testis - interstitial|whole brain|testis|heart,Y,,,,,N,,,,
126,Interactions(IntAct),dbNSFP,4.0c,IntAct interaction,The number of other genes this gene interacting with (from IntAct).,,,PLEKHF2[unassigned1304]|ECM1[unassigned1304]|KRTAP5-7[unassigned1304]|KRT34[unassigned1304]|TRAF2[unassigned1304]|TSC1[unassigned1304]|TRAF1[unassigned1304]|JMJD7[unassigned1304]|KRT31[unassigned1304]|BPIFA1[unassigned1304]|REL[unassigned1304]|PLAGL2[unassigned1304]|TRIB3[unassigned1304]|PRR20D[unassigned1304]|CCHCR1[unassigned1304]|NFKBID[unassigned1304]|ZMYND12[unassigned1304]|RTL8C[unassigned1304]|GLYR1[unassigned1304]; MAGED1[17353931]|ILK[17353931]|HNRNPU[26496610]|FOXQ1[25609649]|HIST1H3A[16322561]|IFI16[25665578]|ATXN7[21078624]|MYC[17353931]|E2F3[22157815]|HIF1AN[26972000]|PHLDA3[17353931]|NOP56[26496610]|FOXB1[25609649]|JUN[25609649]|BRF2[17353931]|EED[26496610]|H3F3A[16322561]|RPS6[29568061]|FOXL1[25609649]|RRP1B[20926688]|GIPC1[17353931]|MNDA[25665578]|LRIF1[16189514]|HIST2H3D[16322561]|PPIB[30021884]|TP53[16322561]; POM121[unassigned1304]|HGS[unassigned1304]|PCDHB12[unassigned1304]; PRKAA2[unassigned1304]|USP54[unassigned1304]|PPP1R32[unassigned1304]|CALCOCO2[unassigned1304]|PXN[unassigned1304]|AKAP8L[unassigned1304]|PPM1J[unassigned1304]|FHL5[unassigned1304]|KRT83[unassigned1304]|CYSRT1[unassigned1304]|ATXN1[unassigned1304]|TP53BP2[25416956|unassigned1304]|KRTAP6-2[unassigned1304]|LPXN[25416956|unassigned1304]|HOXA1[unassigned1304]|TRIM27[25416956]|LZTS2[25416956]|PPP1R16B[unassigned1304]|WWOX[unassigned1304]|ZRANB1[unassigned1304]|ARID5A[unassigned1304]|MTUS2[unassigned1304]|TRAF1[25416956|unassigned1304]|NOTCH2NLA[unassigned1304]|KRT31[unassigned1304]|KRTAP19-6[unassigned1304]|SORBS3[unassigned1304]|RFX6[25416956]|ABI2[unassigned1304]|TRIP6[unassigned1304]|KRT36[unassigned1304]|REL[25416956|unassigned1304]|TAX1BP1[25416956|unassigned1304]|ZNF438[unassigned1304]|TCF4[25416956]|SPERT[25416956|unassigned1304]|NFKBID[unassigned1304]|GLYR1[unassigned1304]; FAM210B[unassigned1304]|GPR152[unassigned1304]|SLC13A4[unassigned1304]|SLC30A2[unassigned1304]|AQP6[unassigned1304]|SLC16A10[unassigned1304]|PEX12[unassigned1304]|TMEM80[unassigned1304]; EEF1B2[20195357]|HSP90AB1[20195357]|RGS3[20195357]|CMSS1[20195357]|KIF5C[20195357]|LRRIQ1[20195357]|LTN1[20195357]|ATP13A4[20195357]|COPG2[20195357]|ZC3H13[20195357]; UBA7[16189514|25416956|unassigned1304|17597759]|ATL3[26259872]|RPN2[26259872]|PRKDC[26259872]|TECR[26259872]|SLC1A5[26259872]|MAGT1[26259872]|USP18[16189514|25416956|unassigned1304|25307056]|RTN4[26259872]|FSTL4[26259872]|SEC61A1[26259872]|EBP[26259872]|SMPD4[26259872]|TMEM43[26259872]|NARS2[26259872]|ARL6IP5[26259872]|FLNB[19270716]|QSOX2[26259872]|KCNN4[26259872]|BCAP31[26259872]|SACM1L[26259872]|SURF4[26259872]|DHCR24[26259872]|NFKB1[25609649]|SLC4A7[26259872]|PPM1B[16872604]|ELF3[17353931]|REEP5[26259872]|DAD1[26259872]|NEDD4[18305167]|OSTC[26259872]|STT3B[26259872]|DHCR7[26259872]|CLPTM1L[26259872]|SEC22B[26259872]|ERGIC3[26259872]|ERGIC1[26259872]; PDIA3[17170699]|TEPSIN[unassigned1304]|APP[10673326|28106549]|GFI1B[16713569]|BOLL[unassigned1304]|NUDCD1[29021621]|ATXN7[21078624]|MAGED1[unassigned1304]|PYHIN1[25665578]|ATN1[16713569]|DAG1[unassigned1793]|CACNA1A[21078624]; TFRC[unassigned1304]|TOMM6[unassigned1304]; RBPMS[25416956]|USHBP1[unassigned1304]|CADPS[25416956]|FHL3[25416956|unassigned1304]|MTUS2[unassigned1304]|NAP1L1[18331838]|PNMA2[25416956]|MEOX2[unassigned1304]|KRT40[25416956]|THAP1[25416956]|TRIP6[25416956]|CEP70[25416956|unassigned1304]|KRT36[unassigned1304]|TRIM27[25416956]|LZTS2[unassigned1304]|CEP76[unassigned1304]|MDFI[25416956|unassigned1304],Y,,,,,N,,,,
127,Interactions(BioGRID),dbNSFP,4.0c,BioGRID interaction,The number of other genes this gene interacting with (from BioGRID),,,TNIP2[27609421]|UBC[23314748]; L3MBTL1[28514442]|SAMD7[26186194|28514442]|NCAPH2[28514442]|TRIM25[29117863]|PRR20E[28514442]|SIRT6[28514442]|HNRNPLL[28514442]|ASB3[28514442]; HIST2H2AA3[16322561]|APP[21832049]|EDA[26186194]|MPG[23537643]|ATN1[16713569]|KIAA0020[26344197]|ILK[17353931]|HNRNPU[26496610]|CHD4[28977666]|CHD3[28977666]|AATF[26344197]|FGF3[28514442]|RRP8[28514442]|FOXQ1[25609649]|MECP2[28514442]|FBL[26344197]|RPS14[28514442]|XPO1[26673895]|FGF8[28514442]|RPL18A[26344197|28514442]|PTTG1[30033366]|SNAPC1[30033366]|DHX15[26344197]|RRP12[26344197]|CPNE2[28514442]|HIF1AN[26972000]|MAGEB10[28514442]|RBM34[28514442]|JAK1[24413661]|DDX18[26344197]|RBFOX1[16713569]|WDR36[26344197]|EED[24457600|26496610]|ZBTB38[26186194]|DDX56[26344197]|DDX54[26344197]|HIST2H2BA[16322561]|SIRT7[22586326]|DDX52[26344197]|FOXL1[25609649]|ILF2[26186194]|GTPBP4[26344197]|FTSJ3[26344197]|EBNA1BP2[26344197]|NSA2[26344197]|HIST4H4[16322561]|DKC1[26344197]|GRWD1[26344197]|MTF1[28416769]|MRTO4[26344197]|RPL27[26344197]|PLEKHO1[28514442]|LRIF1[16189514]|ZNF512[28514442]|TP53[20959462|16322561]|OBSL1[24711643]|GLYR1[26344197]|CUL7[24711643]|DDX24[26344197]|MAGED1[17353931]|SHMT2[22658674]|NOP2[26344197]|MAK16[28514442]|PDGFB[28514442]|RPF2[26344197]|SDAD1[26344197]|RNF4[29180619]|AURKB[20959462]|RNF2[24457600]|NOL6[26344197]|NXF1[22658674]|IFI16[25693804]|ATXN7[21078624]|PES1[26344197|25825154]|RRS1[26344197]|ZNF746[25315684]|RPL18[28514442]|SCN3B[28514442]|NTRK1[25921289]|NOP56[26496610]|FOXB1[25609649]|NPM1[26186194|28514442]|BRF2[17353931]|NIFK[26344197]|PYHIN1[28077445]|DDX31[26344197]|PPP1CA[10637318]|MOV10[22658674]|TBL3[26344197]|CCDC8[24711643]|HIST3H3[16322561]|MDM2[24413661]|CEBPZ[26344197]; CUL3[21145461]|KLHL2[28514442]|PDZK1[28514442]|DCN[26186194|28514442]; RFX6[25416956]|REL[25416956]|TP53BP2[25416956]|TAX1BP1[25416956]|LPXN[25416956]|TCF4[25416956]|TRIM27[25416956]|TRAF1[25416956]|LZTS2[25416956]|SPERT[25416956]; LMNA[24623722]; RGS3[20195357]|SHMT2[22658674]|LTN1[20195357]|PCBD1[20211142]|COPG2[20195357]|PCBD2[20211142]; UBE2D3[17719635]|IFIT5[16009940]|HNRNPU[16009940]|PLOD3[16009940]|UBE2L6[16009940]|ENO1[16884686|16009940|16815975]|PLOD1[16009940]|IFIT1[16009940]|IFIT3[16009940]|IFIT2[16009940]|HERC5[16009940|16815975|24693865]|RGS3[16884686]|CFL1[16009940|16815975]|PLS3[16009940]|TRIM25[17222803]|UBAP2L[16009940]|CCNL1[16009940]|PLS1[16009940]|DDX17[16009940]|ACOT8[16009940]|IFNA14[26186194|28514442]|CSNK2A1[16009940]|ACTN1[16009940]|TMOD3[16009940]|ZNF281[16009940]|DYRK1A[16009940]|ARID5B[16009940]|ACTN4[16009940]|PGD[16009940]|QTRTD1[16009940]|ATXN2L[16009940]|ACLY[16009940]|CIRH1A[16009940]|EEF1A2[16009940]|ZNF318[22939629]|RPL24[16009940]|LAP3[16009940]|SNRNP200[16009940]|PFN1[16009940]|EZR[16009940]|SQSTM1[25429107]|CFTR[26618866]|IFNA10[28514442]|VCP[16009940]|UBA7[16189514|16884686|16009940|22693631|14976209|20975683|25416956]|YTHDC1[16009940]|MEPCE[16009940]|TARS[16009940]|IQGAP1[16009940]|ZC3HAV1[16009940]|AAAS[16009940]|FUT4[16884686]|HELZ2[16009940]|ATP5B[16009940]|ATXN2[16009940]|LDHA[16009940]|CALD1[16009940]|RDH11[16009940]|BAG3[23824909]|PRDX1[16009940|16815975]|STK38[16884686]|G3BP1[16009940]|PGK1[16009940]|SFN[17222803]|MAP4[16009940]|ZC3H15[16009940]|IFNA21[28514442]|HSPA8[16009940|16815975]|XRCC6[16009940]|SMAD4[16009940]|CBX4[16009940]|HSPA4[16884686]|XRCC5[16009940]|TNK2[28514442]|MSN[16009940]|EIF2AK2[16009940]|DSTN[16815975]|EEF2[16009940]|PRDX6[16815975]|GNB2L1[16009940]|IFNW1[28514442]|CLK1[16009940]|HNRNPL[16009940]|HNRNPK[16009940]|FUBP3[16009940]|NACA[16009940]|FASN[16009940]|RPL27A[16009940]|OGDH[16009940]|EIF4G1[16009940]|LGMN[16009940]|TOP2A[16009940]|IFNA5[26186194|28514442]|GPI[16009940]|IFNA4[28514442]|HSP90AB1[16009940]|WDR1[16009940]|IFNA1[28514442]|PPP1R10[16009940]|CLTC[16009940]|GDI2[16009940]|IFNA2[26186194|28514442]|DDX42[16009940]|HSPB1[16815975]|CHD1[16009940]|ELAVL1[16009940]|IFNA8[26186194|28514442]|FARS2[16009940]|PTBP1[16009940]|ATIC[16009940]|SIN3A[16009940]|PHGDH[16009940]|CLIC1[16009940]|CCT3[16009940]|CCT2[16009940]|HSP90AA1[16009940]|WARS[16009940]|ANXA2[16009940]|ANXA3[16009940]|DDX58[16009940]|ANXA5[16009940]|MYOF[16009940]|SEPT2[18305167]|SERPINB5[16009940]|DDB2[16009940]|SENP1[16009940]|WDR33[16009940]|EEF1G[16009940]|ACTA1[16009940]|PPM1B[16884686]|DEPDC7[16009940]|PKM[16009940]|ELF3[17353931]|PALLD[16009940]|MYH9[16009940]|ALDOA[16009940]|TKT[16009940]|GAPDH[16815975]|CHMP5[20164219|16009940]|PAFAH1B1[16009940]|PLEC[16009940]|WIBG[16009940]|SF3B4[16009940]|TAGLN[16009940]|NFIX[16009940]|AHNAK[16009940]|GSTP1[16009940]|ATP5A1[16009940]|USP18[16189514|25307056|25416956]|PSMA7[16009940]|HDAC6[25429107]|HSPD1[16009940]|DNAJB1[16009940]|RBM15B[16009940]|GANAB[16009940]|UGP2[22939629]|RBBP4[16009940]|FAM120C[16009940]|DNAJB4[16009940]|LMAN2[16009940]|LMNA[16009940]|FLNA[16009940]|FLNB[16009940]|NUP43[16009940]|ABCF2[16009940]|RPS27A[16009940]|GBP1[16009940]|IFNL3[28514442]|CCT4[16009940]|SF3A2[16009940]|YTHDF3[16009940]|STAT1[16009940]|USP21[21399617]|TXNRD1[16009940]|GSR[16009940]|MX1[16009940]|NEDD4[18287095]|ERCC2[16884686]|HNRNPA2B1[16009940]|SERBP1[16009940]|CTNNB1[20581239]|EPPK1[16009940]|VIM[16009940]|TAF2[16009940]|RAN[16009940]|HSPA1A[16009940]; PDIA3[17170699]|CRP[28514442]|PYHIN1[28077445]|ATN1[16713569]|CACNA1A[21078624]|TUBG1[23443559]|SKI[25670202]|MOV10[22658674]|NXF1[22658674]|GFI1B[16713569]|OLFM3[28514442]|ZFP41[26186194|28514442]|CAMKV[28514442]|OS9[28514442]|ATXN7[21078624]|UBC[28190767]|DAG1[8205617]; HNRNPL[28611215]|GBP5[28514442]|ARMC6[28514442]|LGALS8[26186194|28514442],Y,,,,,N,,,,
128,Interactions(ConsensusPathDB),dbNSFP,4.0c,ConsensusPathDB interaction,The number of other genes this gene interacting with (from ConsensusPathDB).,,,RTL8C[0.004]|PROP1[0.958]|REL[0.960]|KRT34[0.267]|PLAGL2[0.958]|ECM1[0.004]|CCHCR1[0.963]|KRT31[0.267]|TRAF1[0.067]|GLYR1[0.960]|TRAF2[0.067]|KRTAP5-7[0.262]|SAMD7[0.004]|L3MBTL1[0.962]|HNRNPLL[0.959]|NCAPH2[0.962]|ASB3[0.004]|SIRT6[0.961]; TP53[0.999]|TP53[NA]|AURKB[NA]|TP63[0.999]|EED[0.999]|ATXN7[0.992]|BRF2[0.999]|PHLDA3[0.366]|ATP1A1[NA]|KRT1[NA]|SUN2[NA]|INTS5[NA]|SEC61A1[NA]|INTS3[NA]|KDM1A[NA]|AGPAT5[NA]|HSPA5[NA]|GPAM[NA]|SHOC2[NA]|KRT14[NA]|ALB[NA]|MSH6[NA]|LMNA[NA]|HELLS[NA]|PARP1[NA]|SCD[NA]|IMPA1[NA]|MYO1C[NA]|PGAP1[NA]|GTPBP2[NA]|HNRNPU[NA]|E2F3[NA]|XRCC5[NA]|SLC25A10[NA]|DHX33[NA]|EFTUD2[NA]|NUP93[NA]|RBSN[NA]|INTS6[NA]|PRKDC[NA]|SLC2A1[NA]|IMMT[NA]|AKAP8[NA]|POLG[NA]|CTNNB1[NA]|CTNNA1[NA]|SMARCA1[NA]|KRT9[NA]|MYO1B[NA]|ATP2A2[NA]|L3MBTL3[NA]|TRIM28[NA]|MRPL57[NA]|NDUFS1[NA]|SLC25A5[NA]|RAB13[NA]|MSH2[NA]|ITGB1[NA]|NAT10[NA]|NOLC1[NA]|TRRAP[NA]|AHCTF1[NA]|SLC27A4[NA]|SMPD4[NA]|DDX41[NA]|NUMA1[NA]|WRN[NA]|SFMBT1[NA]|AFG3L2[NA]|MYBBP1A[NA]|SLC25A4[NA]|ENOX2[NA]|TFRC[NA]|HSPA9[NA]|KAT2A[NA]|SP1[NA]|SLC25A3[NA]|RHOT1[NA]|ZBED4[NA]|GPD2[NA]|LRPPRC[NA]|LBR[NA]|TCERG1[NA]|ACADS[NA]|NOTCH3[NA]|ALPI[NA]|SLC25A6[NA]|TRIM23[NA]|EEF1A1[NA]|PMM1[NA]|ATAD3A[NA]|RPS27L[NA]|DDB1[NA]|CPT1A[NA]|HADHA[NA]|TMEM33[NA]|CCDC9[NA]|NCL[NA]|MYO6[NA]|CEBPZ[NA]|NPLOC4[NA]|TCF7L2[NA]|DDX21[NA]|ZNF148[NA]|RB1[NA]|TNXB[NA]|HSPA6[NA]|CLASP1[NA]|HLTF[NA]|MATR3[NA]|TECR[NA]|STT3A[NA]|RPS3[NA]|SLC16A3[NA]|DOCK8[NA]|RFC1[NA]|NUP98[NA]|NUP205[NA]|DHX9[NA]|DHCR7[NA]|XRCC6[NA]|RHOT2[NA]|ZNF300[NA]|PCLO[NA]|ADGRF5[NA]|NCAPG[NA]|ZC3H11A[NA]|SYMPK[NA]|FOXL1[NA]|YY1[NA]|SIX5[NA]|ORC3[NA]|IARS[NA]|INTS3[NA]|STOM[NA]|NOVA1[NA]|RAD50[NA]|NELFCD[NA]|RANBP2[NA]|ECPAS[NA]|TOMM70[NA]|SMARCA5[NA]|MDN1[NA]|DDX39A[NA]|BTAF1[NA]|SATB1[NA]|RMDN3[NA]|PI4KA[NA]|YARS[NA]|HELLS[NA]|ARID3B[NA]|RANGAP1[NA]|UBE4A[NA]|RALY[NA]|GTF3C5[NA]|TOMM40[NA]|ADAR[NA]|LMNB2[NA]|ORC4[NA]|DARS2[NA]|SCRIB[NA]|UTP6[NA]|MRPS30[NA]|SMC3[NA]|GTF3C1[NA]|NR2F1[NA]|IRF9[NA]|CHD1L[NA]|PDS5A[NA]|DCUN1D5[NA]|CPSF2[NA]|SMC4[NA]|NR2C2[NA]|KIF22[NA]|NCAPD2[NA]|CKAP5[NA]|GBF1[NA]|HK2[NA]|DYNC1H1[NA]|ZFHX4[NA]|POLE[NA]|SMARCA1[NA]|NEMP1[NA]|NCAPH[NA]|SNX2[NA]|NSF[NA]|GTF3C4[NA]|EEF1D[NA]|ARID3A[NA]|STAG1[NA]|AARS2[NA]|SMPD4[NA]|SMC1A[NA]|FASN[NA]|SPIDR[NA]|SATB2[NA]|CENPB[NA]|ORC2[NA]|FEN1[NA]|HEATR1[NA]|EIF4G1[NA]|NSDHL[NA]|HSPA14[NA]|HDAC2[NA]|HDAC6[NA]|PA2G4[NA]|SMC2[NA]|RIF1[NA]|MRPL45[NA]|BAZ1A[NA]|UTP20[NA]|ABCF3[NA]|NR3C1[NA]|NOL9[NA]|TLE3[NA]|SMARCAD1[NA]|HK3[NA]|NUP133[NA]|RINT1[NA]|COPA[NA]|GADD45GIP1[NA]|MAP2K3[NA]|NUP98[NA]|NUP205[NA]|DHFR[NA]|UFL1[NA]|VARS[NA]|MRPL38[NA]|GAPVD1[NA]|NCAPG[NA]|COG5[NA]|H3F3A[0.999]|HIST2H3A[0.999]|RANBP2[NA]|SMARCA5[NA]|DDX39A[NA]|SATB1[NA]|BTAF1[NA]|SYMPK[NA]|ORC3[NA]|RBBP5[NA]|IARS[NA]|LRWD1[NA]|ACSL4[NA]|GTF3C5[NA]|ZMYM3[NA]|GTF3C1[NA]|HELLS[NA]|YARS[NA]|MCM6[NA]|GATAD2B[NA]|SF3B2[NA]|UBE4A[NA]|RANGAP1[NA]|PBX1[NA]|SF3A1[NA]|PUM1[NA]|KIF22[NA]|CHD4[NA]|NUP85[NA]|CUX1[NA]|SF3A3[NA]|CTBP2[NA]|PDS5A[NA]|SMC4[NA]|KIF1BP[NA]|ANAPC7[NA]|POGZ[NA]|SMC1A[NA]|ASH2L[NA]|SATB2[NA]|ORC2[NA]|ZNF326[NA]|HEATR1[NA]|SF3B1[NA]|CDC27[NA]|GTF3C3[NA]|MYO1A[NA]|ZFR[NA]|SMARCA1[NA]|GTF3C2[NA]|POLE[NA]|RCC1[NA]|NSF[NA]|NDUFV1[NA]|ZMYM2[NA]|CCAR2[NA]|GTF3C4[NA]|FUBP3[NA]|FOXQ1[NA]|SMC2[NA]|ADNP[NA]|NUP160[NA]|NUP107[NA]|NUP133[NA]|HIC2[NA]|COPA[NA]|ZBTB33[NA]|TLE3[NA]|HNRNPUL2[NA]|ZNF143[NA]|VARS[NA]|HOXD13[NA]|TFCP2[NA]|KIF5B[NA]|NUP98[NA]|NUP205[NA]|HIST1H3A[0.999]|CNOT1[NA]|PHACTR4[NA]|NOTCH2[NA]|BLM[NA]|CEP89[NA]|KCTD15[NA]|NFKBIA[NA]|ZRANB2[NA]|NCKAP5L[NA]|HIF1A[NA]|NKAPD1[NA]|RAVER2[NA]|QRICH1[NA]|TMCO1[NA]|ASB6[NA]|IFRD2[NA]|HBS1L[NA]|MAP3K21[NA]|PPP6R1[NA]|TCF12[NA]|CNN2[NA]|RPL37[NA]|SSR3[NA]|ZGPAT[NA]|EIF4E[NA]|PSMC5[NA]|HACE1[NA]|PSMD10[NA]|PLCH1[NA]|ASB13[NA]|PFKM[NA]|RTFDC1[NA]|HDAC3[NA]|EIF4ENIF1[NA]|CASKIN2[NA]|RELA[NA]|DNAJB6[NA]|NDUFAF4[NA]|ANKRD44[NA]|MAEA[NA]|LZTS2[NA]|SYNE2[NA]|RAVER1[NA]|TNKS[NA]|RPS24[NA]|ATAD1[NA]|PPM1G[NA]|ELOC[NA]|NCOA3[NA]|KIDINS220[NA]|ANKFY1[NA]|BTF3[NA]|ZCCHC14[NA]|CDC20[NA]|TRMT10C[NA]|NFKB2[NA]|EXD2[NA]|RNASEL[NA]|TNRC6B[NA]|GMDS[NA]|SEC61B[NA]|GPATCH8[NA]|MTCH1[NA]|TANK[NA]|KDM3B[NA]|ANKRD28[NA]|OSBPL1A[NA]|LSM11[NA]|MAP3K7[NA]|CEP350[NA]|RPL27[NA]|RIPK4[NA]|HDLBP[NA]|ELOB[NA]|HIF1AN[NA]|TLN2[NA]|COPG1[NA]|PSMC2[NA]|ANKHD1[NA]|CCAR2[NA]|CFAP44[NA]|PPP6R3[NA]|SIK3[NA]|NT5DC2[NA]|ANKRD27[NA]|ATAD3A[NA]|ANKEF1[NA]|ZNF622[NA]|RRP8[NA]|ASB8[NA]|MIB2[NA]|MLF2[NA]|WDR77[NA]|PARP8[NA]|PSMD14[NA]|NOTCH3[NA]|HECTD1[NA]|ZCCHC3[NA]|RPS15[NA]|POLR2B[NA]|ARNT[NA]|ILK[NA]|EHMT1[NA]|UBAP2L[NA]|TNKS2[NA]|VAPA[NA]|ANKRD52[NA]|ZBTB33[NA]|EDC3[NA]|CNOT11[NA]|NFKBIE[NA]|ANKS6[NA]|HAUS4[NA]|MORC4[NA]|FMR1[NA]|PLA2G6[NA]|ANKRD50[NA]|PSMD13[NA]|RPRD2[NA]|ANKS1A[NA]|POLR2L[NA]|ANKRD17[NA]|NAA10[NA]|ZNF131[NA]|NCAPH[NA]|POLE[NA]|GTF3C3[NA]|TLE4[NA]|ZFR[NA]|HK2[NA]|DYNC1H1[NA]|HEATR1[NA]|MRPL27[NA]|SATB2[NA]|SMC1A[NA]|SMPD4[NA]|AARS2[NA]|EEF1D[NA]|ARID3A[NA]|SMC4[NA]|CTBP2[NA]|PDS5A[NA]|UBR5[NA]|NDUFV2[NA]|E4F1[NA]|SF3A3[NA]|GBF1[NA]|NCAPD2[NA]|IQGAP2[NA]|WAPL[NA]|SACM1L[NA]|CTNND1[NA]|ZBTB40[NA]|UBE4A[NA]|RALY[NA]|RANGAP1[NA]|ARID3B[NA]|YARS[NA]|GTF3C1[NA]|MRPS30[NA]|SMC3[NA]|SCRIB[NA]|DARS2[NA]|STAG2[NA]|ADAR[NA]|DARS[NA]|HK3[NA]|GTF3C5[NA]|TOMM40[NA]|NOVA1[NA]|LRWD1[NA]|NUP160[NA]|MRPL45[NA]|MRPL24[NA]|MRPL20[NA]|RIF1[NA]|IARS[NA]|PA2G4[NA]|SMC2[NA]|ANP32C[NA]|SIX5[NA]|SYMPK[NA]|NSDHL[NA]|YY1[NA]|HUWE1[NA]|SATB1[NA]|BTAF1[NA]|DDX39A[NA]|PRPF31[NA]|SMARCA5[NA]|MRPL51[NA]|ECPAS[NA]|RANBP2[NA]|FUBP3[NA]|GTF3C4[NA]|COPG1[NA]|CCAR2[NA]|RCC1[NA]|GTF3C2[NA]|CTNNB1[NA]|SALL1[NA]|ZFHX4[NA]|SF3B1[NA]|DUSP9[NA]|EIF4G1[NA]|NOVA2[NA]|FOXB1[NA]|SKP2[NA]|HOXA10[NA]|QARS[NA]|DHFR[NA]|UFL1[NA]|NUP205[NA]|LARS[NA]|TP53[NA]|MRPL3[NA]|GAPVD1[NA]|MRPL18[NA]|COG5[NA]|MRPL38[NA]|HOXD13[NA]|VARS[NA]|MEN1[NA]|HNRNPUL2[NA]|KPNA1[NA]|TLE3[NA]|MRPL50[NA]|LRP1[NA]|ZBTB33[NA]|TFAP2A[NA]|GADD45GIP1[NA]|COPA[NA]|HIC2[NA]|TLE1[NA]|ILK[0.629]|MAGED1[0.656]|GIPC1[0.292]|NOL10[NA]|SPOUT1[NA]|WDR3[NA]|RPF2[NA]|GAR1[NA]|RRP1[NA]|GPATCH4[NA]|DDX47[NA]|PWP1[NA]|ATXN2L[NA]|REXO4[NA]|NVL[NA]|RBM19[NA]|RBM34[NA]|DDX24[NA]|POP1[NA]|KRR1[NA]|BYSL[NA]|IGF2BP3[NA]|RBM28[NA]|CCDC86[NA]|NOL11[NA]|FAM120A[NA]|DDX52[NA]|UTP14A[NA]|DDX27[NA]|C7orf50[NA]|UTP18[NA]|H2AFX[NA]|SDC1[NA]|SURF6[NA]|ISG20L2[NA]|HP1BP3[NA]|LARP1[NA]|CAPRIN1[NA]|MAK16[NA]|NOP10[NA]|RPF1[NA]|STRBP[NA]|UTP15[NA]|NKRF[NA]|SPATS2L[NA]|CCDC137[NA]|EXOSC2[NA]|LARP4B[NA]|NOP16[NA]|EXOSC10[NA]|PELP1[NA]|PES1[NA]|RRP15[NA]|DDX54[NA]|NSD2[NA]|DHX30[NA]|DHX33[NA]|USP36[NA]|DDX50[NA]|NIFK[NA]|H1FX[NA]|GLYR1[NA]|NOP56[NA]|NOL8[NA]|RPP30[NA]|CENPV[NA]|LARP4[NA]|RRP12[NA]|BRIX1[NA]|WDR12[NA]|NAT10[NA]|PABPC1[NA]|DDX31[NA]|CTCF[NA]|LENG8[NA]|ATXN2[NA]|TENT4B[NA]|LARP7[NA]|MYBBP1A[NA]|URB1[NA]|RRP1B[NA]|AATF[NA]|PABPC4[NA]|YTHDC2[NA]|DKC1[NA]|NHP2[NA]|PDCD11[NA]|ZNF711[NA]|GRWD1[NA]|RRP8[NA]|KNOP1[NA]|DHX57[NA]|NOC3L[NA]|TEX10[NA]|PAK1IP1[NA]|DDX51[NA]|MNDA[NA]|LAS1L[NA]|ZC3HAV1[NA]|ZCCHC3[NA]|NOP53[NA]|NOL6[NA]|EXOSC6[NA]|FTSJ3[NA]|RRP7A[NA]|XRN2[NA]|PPP1CB[NA]|UTP20[NA]|RRS1[NA]|EIF3A[NA]|NSA2[NA]|RACK1[NA]|KRI1[NA]|BOP1[NA]|EXOSC7[NA]|GTPBP4[NA]|NOL9[NA]|NOP2[NA]|PLS3[NA]|HIST1H1E[NA]|PPAN[NA]|STAU2[NA]|WDR36[NA]|EXOSC3[NA]|UPF1[NA]|STAU1[NA]|DDX18[NA]|RIOX1[NA]|IGF2BP1[NA]|DDX21[NA]|GNL3[NA]|CEBPZ[NA]|PPP1CC[NA]|COPA[NA]|DDX6[NA]|NGDN[NA]|NOP58[NA]|PUM3[NA]|RCN2[NA]|DDX10[NA]|TRMT1L[NA]|RSL1D1[NA]|MTREX[NA]|EBNA1BP2[NA]|PNP[NA]|CASC3[NA]|GNL2[NA]|MRTO4[NA]|BMS1[NA]|MKI67[NA]|TBL3[NA]|LYAR[NA]|MOV10[NA]|WDR75[NA]|FBL[NA]|URB2[NA]|MYC[0.999]|RPL5[NA]|USP36[NA]|RPL7L1[NA]|FBL[NA]|MOV10[NA]|TBL3[NA]|LYAR[NA]|ACACB[NA]|MKI67[NA]|BMS1[NA]|MRTO4[NA]|NMNAT1[NA]|GNL2[NA]|EBNA1BP2[NA]|PRKRA[NA]|RSL1D1[NA]|DHX37[NA]|RFC1[NA]|TRMT1L[NA]|NUP205[NA]|REPIN1[NA]|DDX10[NA]|RPS13[NA]|RPL10A[NA]|PUM3[NA]|NGDN[NA]|RPL31[NA]|RSBN1[NA]|ELOA[NA]|RPLP0[NA]|PDCD11[NA]|RPL13[NA]|LLPH[NA]|PWP2[NA]|GZF1[NA]|NOL12[NA]|MRPL11[NA]|TSR1[NA]|AATF[NA]|MRPS31[NA]|MYBBP1A[NA]|RRP1B[NA]|MRPS15[NA]|RPL36A[NA]|NIP7[NA]|CTCF[NA]|NAT10[NA]|BRIX1[NA]|RPL26L1[NA]|WDR12[NA]|ECH1[NA]|DDX55[NA]|NOL8[NA]|H1FX[NA]|NOP56[NA]|BOP1[NA]|RPL19[NA]|ARF4[NA]|KRI1[NA]|RPS14[NA]|LACTB[NA]|RPL17[NA]|UTP20[NA]|RRS1[NA]|ZNF512[NA]|FANCI[NA]|RRBP1[NA]|RPL39[NA]|FTSJ3[NA]|NOL6[NA]|MRPL24[NA]|NOP53[NA]|ZC3HAV1[NA]|RPLP2[NA]|LAS1L[NA]|DDX51[NA]|PAK1IP1[NA]|TEX10[NA]|RPL7A[NA]|NOC3L[NA]|MRPS34[NA]|KNOP1[NA]|RRP8[NA]|GRWD1[NA]|ESF1[NA]|RPS9[NA]|RPS23[NA]|NOL10[NA]|POLRMT[NA]|SDAD1[NA]|RPL18A[NA]|RFC4[NA]|MAK16[NA]|SRP72[NA]|MRPS16[NA]|SLC25A1[NA]|HADHB[NA]|UTP23[NA]|RPL3[NA]|EIF6[NA]|RPL32[NA]|CEBPZ[NA]|GNL3[NA]|RSL24D1[NA]|DDX21[NA]|RPL35A[NA]|RPL18[NA]|MPHOSPH10[NA]|ZNF286A[NA]|DDX18[NA]|GRPEL1[NA]|STAU1[NA]|RIOX1[NA]|MRPL47[NA]|NOM1[NA]|RPLP1[NA]|RPS17[NA]|WDR36[NA]|MRPL28[NA]|MRPS10[NA]|PPAN[NA]|SLC39A7[NA]|RPL4[NA]|RPL14[NA]|RPS6[NA]|RPL36[NA]|PTCD3[NA]|NCL[NA]|MRPS25[NA]|NOP14[NA]|RPL12[NA]|MRPS26[NA]|NEPRO[NA]|RPL7[NA]|HP1BP3[NA]|SURF6[NA]|HAGH[NA]|NOP2[NA]|DDX56[NA]|WDR18[NA]|HADHA[NA]|C7orf50[NA]|NOL9[NA]|RPL13A[NA]|GTPBP4[NA]|DDX27[NA]|DAP3[NA]|NIFK[NA]|DDX50[NA]|SRP68[NA]|DHX33[NA]|RCL1[NA]|DIEXF[NA]|NUP188[NA]|DHX30[NA]|DDX54[NA]|RPL37A[NA]|RPS8[NA]|RRP15[NA]|PES1[NA]|PELP1[NA]|NPM3[NA]|WDR43[NA]|MRPS22[NA]|NOP16[NA]|EXOSC10[NA]|UTP3[NA]|RPS3A[NA]|RPS24[NA]|MCCC1[NA]|CCDC137[NA]|MAP7D1[NA]|RPL30[NA]|NKRF[NA]|RPL26[NA]|IMP3[NA]|IMP4[NA]|NOC4L[NA]|EMD[NA]|DIMT1[NA]|HEATR1[NA]|RPS4X[NA]|BCCIP[NA]|RPL28[NA]|URB1[NA]|ATP2A2[NA]|RPL8[NA]|DDX31[NA]|RRP12[NA]|PARN[NA]|AKAP8L[NA]|GTF3C3[NA]|RPP30[NA]|GLYR1[NA]|LIN28B[NA]|NSUN2[NA]|DDX52[NA]|CCDC86[NA]|PCID2[NA]|MRPS5[NA]|IGF2BP3[NA]|RBM28[NA]|POP1[NA]|KRR1[NA]|BYSL[NA]|DDX24[NA]|MRPS18B[NA]|RPL6[NA]|RFC3[NA]|RBM34[NA]|RPL11[NA]|ZKSCAN8[NA]|NVL[NA]|RBM19[NA]|REXO4[NA]|PWP1[NA]|RRP1[NA]|ABT1[NA]|GPATCH4[NA]|RPF2[NA]|LTV1[NA]|MRPS27[NA]|WDR3[NA]|RPL29[NA]|LRIF1[0.999]|DHX57[NA]|ERCC6[NA]|RPL7A[NA]|NOL6[NA]|SOGA1[NA]|LSG1[NA]|RPS14[NA]|RPS25[NA]|RARS[NA]|KRI1[NA]|RTRAF[NA]|EIF2S3[NA]|JADE2[NA]|GTPBP4[NA]|NOP2[NA]|PINX1[NA]|RPL7[NA]|RPS6[NA]|PPAN[NA]|RPS27[NA]|WDR36[NA]|DDX18[NA]|RIOX1[NA]|MRM1[NA]|DDX21[NA]|GNL3[NA]|RPS15A[NA]|CEBPZ[NA]|RFC4[NA]|RPLP0[NA]|RPS3[NA]|NOP58[NA]|TOP2A[NA]|C8orf33[NA]|RPL10A[NA]|DDX10[NA]|CDC6[NA]|MEPCE[NA]|DHX37[NA]|RFC1[NA]|RSL1D1[NA]|EBNA1BP2[NA]|MAP3K1[NA]|DHX9[NA]|MRTO4[NA]|MKI67[NA]|TBL3[NA]|LYAR[NA]|MLLT6[NA]|FBL[NA]|URB2[NA]|HSD17B10[NA]|RPL5[NA]|LEMD2[NA]|H1FX[NA]|GLYR1[NA]|NOP56[NA]|FAM111A[NA]|DDX55[NA]|CENPV[NA]|RPL22[NA]|RRP12[NA]|BRIX1[NA]|EXOSC9[NA]|NAT10[NA]|GTF3C4[NA]|PRRC2A[NA]|USP10[NA]|NIP7[NA]|RPL8[NA]|DECR1[NA]|RPL23A[NA]|MYBBP1A[NA]|CCDC124[NA]|URB1[NA]|TRMT10C[NA]|TSR1[NA]|WDR74[NA]|RPS4X[NA]|CIRBP[NA]|RPS2[NA]|EIF2B1[NA]|WDR3[NA]|RPL11[NA]|RFC3[NA]|RPL6[NA]|POP1[NA]|RBM28[NA]|RPL23[NA]|RFC5[NA]|ABCF1[NA]|RFC2[NA]|RPS12[NA]|RPL13A[NA]|C7orf50[NA]|UBTF[NA]|LARP1[NA]|ATAD5[NA]|RPL12[NA]|RPL36[NA]|RPL4[NA]|RPL32[NA]|RPL3[NA]|IBTK[NA]|SAMD1[NA]|EIF2B4[NA]|NOP10[NA]|CCDC137[NA]|RPL30[NA]|RPS24[NA]|RPS3A[NA]|PNMA3[NA]|RPL24[NA]|NOP16[NA]|RIOX2[NA]|DEK[NA]|UTP4[NA]|RRP15[NA]|DDX54[NA]|DHX30[NA]|NMT1[NA]|SRP68[NA]|DHX33[NA]|LAS1L[NA]|ZCCHC3[NA]|TEX10[NA]|NOL6[NA]|EXOSC6[NA]|FTSJ3[NA]|NOP53[NA]|PNO1[NA]|TRIP12[NA]|NOC3L[NA]|CACYBP[NA]|KRI1[NA]|RACK1[NA]|NSA2[NA]|S100A8[NA]|HSPA4L[NA]|G3BP1[NA]|BOP1[NA]|CTSD[NA]|EIF3A[NA]|RRS1[NA]|UTP20[NA]|DCAF13[NA]|NOP14[NA]|PPAN[NA]|HIST1H1E[NA]|GTPBP4[NA]|SRRM2[NA]|NOP2[NA]|NARS[NA]|DNAJC9[NA]|COPA[NA]|PELO[NA]|ZMPSTE24[NA]|DDX18[NA]|UPF1[NA]|ATXN10[NA]|WDR36[NA]|GNL3[NA]|CEBPZ[NA]|DDX21[NA]|RCC2[NA]|TRMT1L[NA]|RCN2[NA]|DDX10[NA]|WDR46[NA]|NGDN[NA]|PUM3[NA]|ACTR3[NA]|NOP58[NA]|PHIP[NA]|MOV10[NA]|WDR75[NA]|MKI67[NA]|BMS1[NA]|LYAR[NA]|TBL3[NA]|KIF5B[NA]|SNRNP70[NA]|VARS[NA]|PNP[NA]|RSL1D1[NA]|MTREX[NA]|MAP1B[NA]|EBNA1BP2[NA]|MRTO4[NA]|XRCC6[NA]|UTP4[NA]|PES1[NA]|PELP1[NA]|RRP15[NA]|GNL2[NA]|PABPC1[NA]|CCAR2[NA]|S100A9[NA]|USP10[NA]|RANBP1[NA]|NAT10[NA]|DNMT1[NA]|SERBP1[NA]|CENPV[NA]|H1FX[NA]|TBCB[NA]|WDR12[NA]|BRIX1[NA]|RRP12[NA]|FEN1[NA]|PDIA4[NA]|UCHL1[NA]|PWP2[NA]|HIST1H1C[NA]|LLPH[NA]|DKC1[NA]|MAT2A[NA]|PDCD11[NA]|EIF3L[NA]|MCM4[NA]|MYBBP1A[NA]|C1QBP[NA]|SAFB[NA]|SARS2[NA]|BTF3[NA]|PABPC4[NA]|TSR1[NA]|HELZ[NA]|NVL[NA]|RRP1[NA]|PWP1[NA]|RBM34[NA]|IFI16[NA]|NUFIP2[NA]|NOL10[NA]|EMG1[NA]|RPF2[NA]|NOL11[NA]|MSH6[NA]|ATIC[NA]|UTP14A[NA]|NSUN2[NA]|ABCF1[NA]|SMARCA5[NA]|DDX24[NA]|KRR1[NA]|POP1[NA]|RBM28[NA]|SLTM[NA]|USP7[NA]|PEG10[NA]|C7orf50[NA]|DDX27[NA]|HP1BP3[NA]|H2AFX[NA]|CAPRIN1[NA]|MAK16[NA]|UTP6[NA]|NUDT5[NA]|ADAR[NA]|MPHOSPH10[NA]|PPM1G[NA]|LARP4B[NA]|DNTTIP2[NA]|FKBP4[NA]|NKRF[NA]|RNH1[NA]|NIFK[NA]|DDX50[NA]|SAFB2[NA]|CHD4[NA]|HAT1[NA]|EXOSC10[NA]|NOP16[NA]|WDR43[NA]|XRCC5[NA]|EIF3C[NA]|DDX54[NA]|RRP9[NA]|ABCF1[NA]|LCOR[NA]|PHF19[NA]|RPL9[NA]|SUZ12[NA]|TCEA1[NA]|AEBP2[NA]|DDX21[NA]|EZH2[NA]|TFAP2A[NA]|NOP2[NA]|GTPBP4[NA]|JARID2[NA]|DDX10[NA]|EPOP[NA]|RBBP7[NA]|EED[NA]|PHF1[NA]|MTF2[NA]|RBBP4[NA]|RBFOX1[0.936]|ATN1[0.949]|PPP1CA[0.993]|AURKB[0.999]|SIRT7[0.999]|HIST3H3[0.999]|HIST2H2AA3[0.015]|HIST1H4A[0.017]|APP[0.328]|MPG[0.999]|MDM2[0.999]|JAK1[0.805]|CUL7[0.990]|OBSL1[0.934]|CCDC8[0.032]|RNF2[0.999]|NPM1[0.999]|ZBTB38[0.940]|ILF2[0.999]|EDA[0.355]|CEBPZ[0.986]|DDX52[0.999]|DDX54[0.999]|NIFK[0.999]|AATF[0.997]|DDX18[0.999]|DDX24[0.999]|DDX31[0.999]|DDX56[0.999]|DHX15[0.999]|DKC1[0.999]|EBNA1BP2[0.999]|FBL[0.999]|FTSJ3[0.999]|GLYR1[0.979]|GRWD1[0.999]|GTPBP4[0.999]|PUM3[0.999]|MRTO4[0.999]|NOP2[0.999]|NSA2[0.999]|PES1[0.999]|RPL18A[0.999]|RPL27[0.998]|RRP12[0.997]|RRS1[0.999]|TBL3[0.999]|WDR36[0.034]|NOL6[0.999]|RPF2[0.999]|SDAD1[0.999]|NTRK1[0.716]|IFI16[0.999]|XPO1[0.999]|HNRNPU[0.999]|NOP56[0.999]|FOXB1[0.999]|FOXL1[0.999]|FOXQ1[0.999]|ZNF746[0.993]|MAK16[0.999]|RPL18[0.997]|MAGEB10[0.005]|FGF8[0.006]|RPS14[0.999]|PDGFB[0.885]|FGF3[0.304]|PLEKHO1[0.797]|RRP8[0.999]|RBM34[0.999]|MECP2[0.991]|SCN3B[0.323]|ZNF512[0.944]|CPNE2[0.005]|MTF1[0.939]; ACTC1[0.977]|CUL3[0.665]|DCN[0.005]|KLHL2[0.939]|PDZK1[0.955]; TRAF1[0.005]|TRIP6[0.024]|KRT36[0.004]|TAX1BP1[0.005]|KRT83[0.005]|WWOX[0.004]|AKAP8L[0.004]|USP54[0.004]|PRKAA2[0.019]|ATXN1[0.005]|TCF4[0.004]|KRTAP6-2[0.005]|TP53BP2[0.004]|PPP1R32[0.006]|LPXN[0.006]|LZTS2[0.005]|RFX6[0.005]|HOXA1[0.005]|KRTAP19-6[0.005]|MTUS2[0.004]|ZRANB1[0.004]|CALCOCO2[0.013]|REL[0.005]|ARID5A[0.005]|SORBS3[0.005]|CYSRT1[0.015]|SPERT[0.005]|KRT31[0.005]|NCK2[0.014]|TRIM27[0.005]|ABI2[0.005]|CCDC57[0.004]|DEF6[0.004]|PPM1J[0.004]|GLYR1[0.004]|PXN[0.012]; SLC30A2[0.004]|SLC13A4[0.004]|LMNA[0.004]; RGS3[0.967]|ZC3H13[0.005]|ATP13A4[0.005]|HSP90AB1[0.967]|CMSS1[0.004]|COPG2[0.528]|EEF1B2[0.079]|LTN1[0.005]|LRRIQ1[0.004]|KIF5C[0.317]|PCBD1[0.969]|PCBD2[0.005]; UBA7[0.999]|NEDD4[0.943]|UBE2L6[0.999]|PPM1B[0.979]|FLNB[0.930]|IRF3[0.993]|PCNA[0.608]|XRCC6[0.567]|IRF9[0.985]|EZR[0.192]|CSNK2A1[0.533]|SMAD4[0.527]|PLOD1[0.984]|HNRNPK[0.153]|ANXA5[0.878]|EIF2AK2[0.989]|WDR33[0.986]|AHNAK[0.098]|ATXN2L[0.005]|DDX17[0.411]|SERPINB5[0.998]|TXNRD1[0.644]|TOP2A[0.174]|EEF1G[0.822]|DDB2[0.318]|EEF1A2[0.215]|TMOD3[0.113]|PGD[0.847]|CALD1[0.331]|CREBBP[NA]|IRF3[NA]|VCP[0.966]|PSMA7[0.584]|RACK1[0.127]|ACTN4[0.793]|PPP1R10[0.033]|UBAP2L[0.087]|LMNA[0.164]|ARID5B[0.032]|STAT1[NA]|STAT2[NA]|IRF9[NA]|EP300[0.723]|IRF4[0.980]|PLOD3[0.204]|HNRNPU[0.178]|MX1[0.993]|IRF1[NA]|IRF9[NA]|IFIT3[0.005]|PLS1[0.532]|STAT1[0.967]|RPL27A[0.922]|UBE2N[0.969]|PTBP1[0.047]|PFN1[0.081]|IRF8[0.992]|IRF7[0.979]|IFIT1[0.994]|G3BP1[0.637]|ENO1[0.892]|TKT[0.657]|DYRK1A[0.041]|HSP90AB1[0.988]|VIM[0.514]|LAP3[0.186]|CLIC1[0.040]|RELA[0.984]|CBX4[0.201]|PAFAH1B1[0.219]|NUP43[0.419]|IRF1[0.987]|RAN[0.595]|CLTC[0.968]|IQGAP1[0.415]|FUBP3[0.108]|UTP4[0.029]|FLNA[0.954]|ALDOA[0.999]|EIF4G1[0.990]|HNRNPL[0.106]|PLEC[0.258]|OGDH[0.402]|FASN[0.759]|IFIT5[0.004]|ACLY[0.921]|YTHDC1[0.036]|SIN3A[0.071]|HSPD1[0.961]|ZNF281[0.038]|CCT4[0.858]|GSTP1[0.890]|MYH9[0.232]|STAT1[NA]|STAT2[NA]|MYNN[0.029]|SNRNP200[0.046]|LGMN[0.771]|CCNL1[0.032]|CLK1[0.114]|FARS2[0.247]|HSPA8[0.965]|HSP90AA1[0.965]|FAM120C[0.004]|SF3B4[0.044]|CHMP5[0.631]|ACOT8[0.410]|MSN[0.069]|TARS[0.780]|ANXA3[0.118]|SERBP1[0.174]|EEF2[0.968]|ANXA2[0.983]|ACTA1[0.692]|ATIC[0.880]|DNAJB1[0.117]|RDH11[0.118]|MED14[0.048]|GPI[0.999]|LDHA[0.876]|SF3A2[0.056]|SENP1[0.127]|IRF2[0.953]|PRDX1[0.369]|CFL1[0.558]|CCT3[0.650]|DDX58[0.996]|RPS27A[0.982]|HSPA1A[0.940]|LMAN2[0.315]|MAP4[0.103]|TAGLN[0.579]|RPL24[0.960]|PYM1[0.101]|CCT2[0.985]|ACTN1[0.758]|CREBBP[0.707]|WARS[0.740]|ATXN2[0.346]|TAF2[0.043]|WDR1[0.995]|ELAVL1[0.672]|GDI2[0.887]|PKM[0.938]|STAT1[NA]|IRF9[NA]|ABCF2[0.170]|ZC3H15[0.173]|PHGDH[0.999]|RBBP4[0.063]|ATP5F1A[0.418]|SPI1[0.353]|EPPK1[0.099]|GSR[0.738]|AAAS[0.182]|IRF1[NA]|IRF2[NA]|HNRNPA2B1[0.129]|CHD1[0.106]|MYOF[0.122]|GANAB[0.506]|DDX42[0.101]|HERC5[0.997]|USP18[0.992]|RTN4[NA]|MAGT1[NA]|ELF3[0.250]|HSPA1L[NA]|HNRNPK[NA]|PIP[NA]|HIST1H2AA[NA]|SFXN1[NA]|HIST1H1B[NA]|ALOX12B[NA]|HSPD1[NA]|CHD3[NA]|RPS3[NA]|FBL[NA]|AZGP1[NA]|NFKB1[NA]|LRRIQ4[NA]|TRIM72[NA]|TUBA4A[NA]|HSPA8[NA]|ALDH5A1[NA]|VARS[NA]|GAPDH[NA]|ACTBL2[NA]|TUFM[NA]|MSH2[NA]|UQCRC2[NA]|RPS18[NA]|PSMC2[NA]|RAN[NA]|PRKDC[NA]|DIRAS2[NA]|ACTA2[NA]|HSPA9[NA]|TARDBP[NA]|HIST1H1C[NA]|APRT[NA]|HK1[NA]|MRPS31[NA]|BLMH[NA]|PRSS1[NA]|RIF1[NA]|HSP90AB1[NA]|ALPI[NA]|CDK1[NA]|HNRNPH1[NA]|SLC1A5[NA]|NSDHL[NA]|LRPPRC[NA]|RPS14[NA]|VIM[NA]|HNRNPA2B1[NA]|ACTB[NA]|EEF1A1[NA]|PRSS3[NA]|PDHB[NA]|TUBB4A[NA]|TUBB4B[NA]|A2ML1[NA]|PARP1[NA]|INA[NA]|AIFM1[NA]|C4orf19[NA]|ATP5F1A[NA]|SLC25A12[NA]|LMNB1[NA]|FRMD8[NA]|ELAVL1[NA]|PRPH[NA]|MTHFD1[NA]|HIST1H2BB[NA]|KPNA2[NA]|RUVBL2[NA]|SLC25A13[NA]|VTN[NA]|EIF4A1[NA]|SYNCRIP[NA]|FKBP8[NA]|RBMX[NA]|PRDX1[NA]|CDSN[NA]|SSR1[NA]|REL[NA]|ANKRD24[NA]|RPS16[NA]|TUBB1[NA]|DDX21[NA]|IGF2BP1[NA]|RPS15A[NA]|TUBB2A[NA]|CAT[NA]|HSPA6[NA]|RPS10P5[NA]|NAV3[NA]|CEP112[NA]|HIST1H1A[NA]|GGCT[NA]|GNAS[NA]|RPS3A[NA]|TUBB3[NA]|HIST1H2BC[NA]|STXBP4[NA]|OAT[NA]|HSP90AB2P[NA]|HOXC8[NA]|HNRNPU[NA]|CCT3[NA]|ATP5F1B[NA]|HPF1[NA]|HIST1H4A[NA]|PFKP[NA]|RUVBL1[NA]|HIST1H2AB[NA]|MAP3K8[NA]|TUBG1[NA]|SEMG2[NA]|ANXA2[NA]|CKAP5[NA]|SEMG1[NA]|RELA[NA]|COPB2[NA]|HNRNPM[NA]|IGKC[NA]|HIST1H2BA[NA]|BSG[NA]|PSMC3[NA]|TFAM[NA]|SLC25A5[NA]|PSMD2[NA]|EEF1G[NA]|TTF2[NA]|SLC25A4[NA]|RPS4X[NA]|H1F0[NA]|CFAP73[NA]|DBT[NA]|RPS10[NA]|EEF1D[NA]|TUBB[NA]|JCHAIN[NA]|NFKB2[NA]|RPL11[NA]|ETFA[NA]|NPEPPS[NA]|SBSN[NA]|DDX17[NA]|FARSA[NA]|HSPA2[NA]|SNRPB[NA]|ATP1A1[NA]|PKM[NA]|PRDX2[NA]|NSUN2[NA]|IRS4[NA]|TOMM22[NA]|DDX39A[NA]|TNIP2[NA]|HSPA5[NA]|TMEM43[NA]|SLC1A5[NA]|KCNN4[NA]|ATL3[NA]|DHCR7[NA]|QSOX2[NA]|TECR[NA]|MAGT1[NA]|STT3B[NA]|RTN4[NA]|DHCR24[NA]|BCAP31[NA]|SEC22B[NA]|SMPD4[NA]|OSTC[NA]|FSTL4[NA]|PRKDC[NA]|ARL6IP5[NA]|SEC61A1[NA]|REEP5[NA]|ERGIC3[NA]|SLC4A7[NA]|RPN2[NA]|DAD1[NA]|EBP[NA]|SACM1L[NA]|SURF4[NA]|ERGIC1[NA]|CLPTM1L[NA]|NARS2[NA]|PPM1B[NA]|IFNB1[NA]|PPM1B[NA]|UBA7[NA]|UBE2E2[NA]|SEPT2[0.124]|UBE2D3[0.984]|RGS3[0.676]|ERCC2[0.531]|HSPA4[0.808]|STK38[0.096]|FUT4[0.075]|ATP5F1B[0.422]|YTHDF3[0.004]|RBM15B[0.035]|DNAJB4[0.111]|MEPCE[0.006]|GBP1[0.967]|IFIT2[0.115]|DEPDC7[0.004]|PALLD[0.089]|NFIX[0.033]|PGK1[0.876]|PLS3[0.547]|HELZ2[0.033]|QTRT2[0.295]|XRCC5[0.583]|ZC3HAV1[0.162]|TRIM25[0.993]|SFN[0.996]|USP21[0.007]|DSTN[0.208]|GAPDH[0.661]|HSPB1[0.459]|PRDX6[0.988]|CTNNB1[0.643]|UGP2[0.730]|ZNF318[0.111]|BAG3[0.606]|HDAC6[0.466]|SQSTM1[0.972]|IFNA14[0.999]|IFNA2[0.999]|IFNA5[0.999]|IFNA8[0.999]|IFNW1[0.999]|IFNA1[0.999]|IFNA21[0.999]|TNK2[0.191]|IFNA10[0.999]|IFNA4[0.999]|IFNL3[0.999]; NCAM1[0.998]|DAG1[0.991]|LRP4[NA]|MUSK[NA]|MUSK[NA]|SRC[NA]|RAPSN[NA]|CHRNG[NA]|CHRNB1[NA]|CACNA1A[0.246]|ATXN7[0.012]|APP[0.993]|PDIA3[0.010]|PHIP[NA]|COL18A1[NA]|FOXC1[NA]|ZNF646[NA]|GPC4[NA]|DAXX[NA]|HTATSF1[NA]|RCN2[NA]|XRCC6[NA]|MDC1[NA]|RSL1D1[NA]|MAP1B[NA]|MKI67[NA]|LIG3[NA]|H1FX[NA]|MCM2[NA]|RBBP7[NA]|UBN1[NA]|CTCF[NA]|CCAR2[NA]|RAI1[NA]|ZMYM2[NA]|C5orf24[NA]|NUMA1[NA]|MCM4[NA]|HIST1H1C[NA]|UCHL1[NA]|PHF14[NA]|ZNF428[NA]|ZNF711[NA]|TEX10[NA]|LAS1L[NA]|NR2F2[NA]|RREB1[NA]|BAZ1A[NA]|YWHAH[NA]|SATB1[NA]|MBD1[NA]|DDB1[NA]|SDC1[NA]|SRRM2[NA]|TFAP2A[NA]|DCAF1[NA]|MGA[NA]|GTPBP4[NA]|USP7[NA]|HIST1H1E[NA]|PARP1[NA]|UBN2[NA]|RFX1[NA]|ZNF148[NA]|H2AFY2[NA]|BAZ2A[NA]|NBN[NA]|COPA[NA]|DNAJC9[NA]|YWHAG[NA]|ZMYM4[NA]|TWNK[NA]|HIRA[NA]|SENP3[NA]|HIST1H4A[NA]|ZNF384[NA]|LAMB1[NA]|PPM1G[NA]|NR2C2[NA]|HSPG2[NA]|PELP1[NA]|XRCC5[NA]|SUPT5H[NA]|SDC2[NA]|CHD4[NA]|SAFB2[NA]|TMPO[NA]|NCOA5[NA]|RNH1[NA]|DNAJC7[NA]|SMARCA1[NA]|TTF2[NA]|ATRX[NA]|SUPT16H[NA]|PYHIN1[NA]|TFAM[NA]|CBX5[NA]|PARP2[NA]|BAZ1B[NA]|SAFB[NA]|C1QBP[NA]|SATB2[NA]|MECP2[NA]|TBP[NA]|HOXA13[NA]|RSF1[NA]|ATP6V1B2[NA]|RAD50[NA]|CABIN1[NA]|U2AF1[NA]|SMARCA5[NA]|NSUN2[NA]|LAMC1[NA]|TCF20[NA]|ATIC[NA]|PGK1[NA]|HMBOX1[NA]|HUWE1[NA]|ATN1[0.011]|GFI1B[0.012]|TUBG1[0.016]|ZFP41[0.009]|SKI[0.210]|CAMKV[0.007]|CRP[0.999]|OS9[0.057]|OLFM3[0.999]|UBC[0.109]; LGALS8[0.004]|ARMC6[0.004]|GBP5[0.218]; CEP70[0.995]|RBPMS[0.619]|THAP1[0.958]|MDFI[0.629]|KRT40[0.946]|PNMA2[0.917]|FHL3[0.811]|TRIM27[0.997]|KRT36[0.004]|LZTS2[0.606]|NAP1L1[0.916]|USHBP1[0.004]|TRIP6[0.849]|CEP76[0.617]|MEOX2[0.607]|MTUS2[0.630]|CADPS[0.743],Y,,,,,N,,,,
129,P(HI),dbNSFP,4.0c,,Estimated probability of haploinsufficiency of the gene(from doi:10.1371/journal.pgen.1001154),,,0.06092; 0.15855; 0.10109; 0.24042; 0.09980; 0.19904; 0.06703; 0.20655; 0.10000; 0.40227,N,,,,,N,,,,
130,HIPred_score,dbNSFP,4.0c,,Estimated probability of haploinsufficiency of the gene(from doi:10.1093/bioinformatics/btx028),,,0.186891868710518; 0.263579308986664; 0.51941329240799; 0.352169781923294; 0.146139457821846; 0.285495072603226; 0.460647642612457; 0.636561334133148; 0.412388771772385; 0.309710115194321,N,,,,,N,,,,
131,HIPred,dbNSFP,4.0c,,HIPred prediction of haploinsufficiency of the gene. Y(es) or N(o).(from doi:10.1093/bioinformatics/btx028),,,N; Y,N,,,,,N,,,,
132,GHIS,dbNSFP,4.0c,,A score predicting the gene haploinsufficiency. The higher the score the more likely the gene is haploinsufficient. (from doi: 10.1093/nar/gkv474),,,0.526388187; 0.641794967; 0.546707473; 0.551744031; 0.480431284; 0.510442854; 0.573494831; 0.443129556; 0.530395714; 0.585766194,N,,,,,N,,,,
133,P(rec),dbNSFP,4.0c,,Estimated probability that gene is a recessive disease gene (from DOI:10.1126/science.1215040),,,0.07159; 0.08067; 0.13894; 0.09909; 0.09620; 0.11867; 0.22633; 0.64499; 0.16362; 0.35502,N,,,,,N,,,,
134,Known_rec_info,dbNSFP,4.0c,Known recessive status,Known recessive status of the gene (f2rom DOI:10.1126/science.1215040);lof-tolerant = seen in homozygous state in at least one 1000G individual;recessive = known OMIM recessive disease,,,recessive; lof-tolerant,N,,,,,N,,,,
135,RVIS_EVS,dbNSFP,4.0c,RVIS(ESP6500),"Residual Variation Intolerance Score, a measure of intolerance of mutational burden, the higher the score the more tolerant to mutational burden the gene is. Based on EVS (ESP6500) data. from doi:10.1371/journal.pgen.1003709",,,0.04; -2.65; 0.9; -0.12; -0.22; -0.23; 3.27; -0.6; -0.41; 1.77,N,,,,,N,,,,
136,RVIS_percentile_EVS,dbNSFP,4.0c,RVIS(ESP6500) percentile,"The percentile rank of the gene based on RVIS, the higher the percentile the more tolerant to mutational burden the gene is. Based on EVS (ESP6500) data.",,,56.27; 0.75; 89.33; 45.13; 37.33; 37.11; 99.4; 18.14; 26.23; 96.78,N,,,,,N,,,,
137,LoF-FDR_ExAC,dbNSFP,4.0c,LoF-FDR (ExAC),A gene's corresponding FDR p-value for preferential LoF depletion among the ExAC population. Lower FDR corresponds with genes that are increasingly depleted of LoF variants.,,,0.9905209; 0.3568659; 0.6597935; 0.3751482; 0.1809803; 0.9993496; 0.8494748; 4.90286E-06; 0.4954952; 0.6738169,N,,,,,N,,,,
140,ExAC_pLI,dbNSFP,4.0c,pLI (ExAC),the probability of being loss-of-function intolerant (intolerant of both heterozygous and homozygous lof variants) based on ExAC r0.3 data,available from ExAC,,0.176329298172162; 1.35381157129201e-10; 1.33038194561114e-19; 2.51676266070248e-07; 2.01974835522321e-08; 0.00014794288110518; 0.00984781293610986; 0.17335234048116; 0.0908776364218918; 1.94738806982348e-05,N,,,,,N,,,,
141,ExAC_pRec,dbNSFP,4.0c,pRec (ExAC),"the probability of being intolerant of homozygous, but not heterozygous lof variants based on ExAC r0.3 data",,,0.644086264144236; 0.18370000637236; 0.0025628417280481; 0.722913600252338; 0.659994782009553; 0.245981533859779; 0.600249312746062; 0.826647657926747; 0.765691410287669; 0.46328044912402,N,,,,,N,,,,
142,ExAC_pNull,dbNSFP,4.0c,pNull (ExAC),the probability of being tolerant of both heterozygous and homozygous lof variants based on ExAC r0.3 data,,,0.179584437683602; 0.816299993492259; 0.997437158271952; 0.277086148071396; 0.340005197792964; 0.753870523259116; 0.389902874317828; 1.59209302093807e-09; 0.143430953290439; 0.536700076995282,N,,,,,N,,,,
143,ExAC_nonTCGA_pLI,dbNSFP,4.0c,pLI (ExAC nonTCGA),the probability of being loss-of-function intolerant (intolerant of both heterozygous and homozygous lof variants) based on ExAC r0.3 nonTCGA subset,,,0.550302420215064; 3.87526200981969e-10; 1.95434996883495e-19; 4.71815672240551e-06; 5.57433430125823e-08; 0.000129277219206069; 0.00889061739074356; 0.0403025247483816; 0.338519010089551; 9.62326935096604e-05,N,,,,,N,,,,
144,ExAC_nonTCGA_pRec,dbNSFP,4.0c,pRec (ExAC nonTCGA),"the probability of being intolerant of homozygous, but not heterozygous lof variants based on ExAC r0.3 nonTCGA subset",,,0.39663970580189; 0.177866269557236; 0.00167039389288093; 0.850701626623057; 0.639081791583738; 0.229411510944876; 0.578754997482166; 0.95969745668599; 0.601909186208019; 0.565670299146937,N,,,,,N,,,,
145,ExAC_nonTCGA_pNull,dbNSFP,4.0c,pNull (ExAC nonTCGA),the probability of being tolerant of both heterozygous and homozygous lof variants based on ExAC r0.3 nonTCGA subset,,,0.0530578739830465; 0.822133730055238; 0.998329606107119; 0.149293655220221; 0.360918152672919; 0.770459211835918; 0.41235438512709; 1.85656278974184e-08; 0.05957180370243; 0.434233468159553,N,,,,,N,,,,
146,ExAC_nonpsych_pLI,dbNSFP,4.0c,pLI (ExAC nonpsych),the probability of being loss-of-function intolerant (intolerant of both heterozygous and homozygous lof variants) based on ExAC r0.3 nonpsych subset,,,0.179613130021276; 2.28931804207666e-08; 1.42787593106998e-16; 6.50733790988587e-07; 2.94867415806838e-07; 0.00890752979462469; 0.0584431202198305; 0.432276824423558; 0.0833297729176883; 8.77227114766998e-05,N,,,,,N,,,,
147,ExAC_nonpsych_pRec,dbNSFP,4.0c,pRec (ExAC nonpsych),"the probability of being intolerant of homozygous, but not heterozygous lof variants based on ExAC r0.3 nonpsych subset",,,0.623408532464667; 0.42248722639092; 0.0104452108536494; 0.659119875314906; 0.727056610292468; 0.549074235627792; 0.687740607257902; 0.56772317046328; 0.736478134286935; 0.51582495828253,N,,,,,N,,,,
148,ExAC_nonpsych_pNull,dbNSFP,4.0c,pNull (ExAC nonpsych),the probability of being tolerant of both heterozygous and homozygous lof variants based on ExAC r0.3 nonpsych subset,,,0.196978337514057; 0.5775127507159; 0.98955478914635; 0.340879473951303; 0.272943094840116; 0.442018234577583; 0.253816272522267; 5.11316184674638e-09; 0.180192092795376; 0.484087319005993,N,,,,,N,,,,
149,gnomAD_pLI,dbNSFP,4.0c,pLI (gnomAD),the probability of being loss-of-function intolerant (intolerant of both heterozygous and homozygous lof variants) based on gnomAD 2.1 data,available from gnomAD,,3.0650e-02; 1.3168e-02; 2.5957e-07; 2.6426e-29; 1.1416e-16; 1.8027e-03; 2.5764e-02; 3.9557e-01; 1.0785e-01; 2.5897e-02,N,,,,,N,,,,
150,gnomAD_pRec,dbNSFP,4.0c,pRec (gnomAD),"the probability of being intolerant of homozygous, but not heterozygous lof variants based on gnomAD 2.1 data",,,6.1116e-01; 6.7560e-01; 3.0148e-01; 4.9621e-05; 1.9831e-02; 7.3042e-01; 5.7614e-01; 4.8061e-01; 8.8620e-01; 5.7719e-01,N,,,,,N,,,,
151,gnomAD_pNull,dbNSFP,4.0c,pNull (gnomAD),the probability of being tolerant of both heterozygous and homozygous lof variants based on gnomAD 2.1 data,,,3.5819e-01; 3.1123e-01; 6.9852e-01; 9.9995e-01; 9.8017e-01; 2.6777e-01; 3.9809e-01; 1.2383e-01; 5.9548e-03; 3.9692e-01,N,,,,,N,,,,
152,ExAC_del.score,dbNSFP,4.0c,Deletion intolerance z-core,Winsorised deletion intolerance z-score based on ExAC r0.3.1 CNV data,,,-1.30231557829469; -1.28066949641572; -1.85618066193215; -2.54252356721664; -0.854090636010466; -0.655956146050992; -0.195411282716471; -0.107338132620471; -0.411262678743063; -0.0672591593714552,N,,,,,N,,,,
153,ExAC_dup.score,dbNSFP,4.0c,Duplication intolerance z-score,Winsorised duplication intolerance z-score based on ExAC r0.3.1 CNV data,,,-2.53125239294469; -2.25597869426552; -1.63096181793128; -1.66066626021856; -0.871382761831082; -1.547525137109; -0.879111583779016; -1.38938551075959; -0.394193176188832; -1.22487190884017,N,,,,,N,,,,
154,ExAC_cnv.score,dbNSFP,4.0c,CNV intolerance z-score,Winsorised cnv intolerance z-score based on ExAC r0.3.1 CNV data,V1,,-2.47162789907313; -2.31189826471188; -2.3252444322095; -1.53319165737073; -1.45000690532075; -0.676226119735614; -1.22537295612016; -0.823164297355822; -1.07852675058797; -0.165089002943554,N,,,,,N,,,,
155,ExAC_cnv_flag,dbNSFP,4.0c,CNV flag,Gene is in a known region of recurrent CNVs mediated by tandem segmental duplications and intolerance scores are more likely to be biased or noisy from ExAC r0.3.1 CNV release,V1,,N; Y,N,,,,,N,,,,
156,GDI,dbNSFP,4.0c,Gene damage index (GDI),"gene damage index score, a genome-wide, gene-level metric of the mutational damage that has accumulated in the general population from doi: 10.1073/pnas.1518646112. The higher the score the less likely the gene is to be responsible for monogenic diseases.",,,113.16669; 835.24604; 783.46189; 60.97395; 709.4528; 1800.58057; 1374.86701; 1338.6014; 350.3187; 56.85253,N,,,,,N,,,,
159,GDP_mendelian,dbNSFP,4.0c,Gene damage prediction (all Mendelian disease-causing genes),gene damage prediction (low/medium/high) by GDI for all Mendelian diseases,,,Medium; High; Low,N,,,,,N,,,,
160,GDP_mendelian_AD,dbNSFP,4.0c,Gene damage prediction (Mendelian AD disease-causing genes),gene damage prediction (low/medium/high) by GDI for Mendelian autosomal dominant diseases,,,Medium; High; Low,N,,,,,N,,,,
161,GDP_mendelian_AR,dbNSFP,4.0c,Gene damage prediction (Mendelian AR disease-causing genes),gene damage prediction (low/medium/high) by GDI for Mendelian autosomal recessive diseases,,,Medium; High; Low,N,,,,,N,,,,
162,GDP_PID,dbNSFP,4.0c,Gene damage prediction (all PID disease-causing genes),gene damage prediction (low/medium/high) by GDI for all primary immunodeficiency diseases,,,Medium; High; Low,N,,,,,N,,,,
163,GDP_PID_AD,dbNSFP,4.0c,Gene damage prediction (PID AD disease-causing genes),gene damage prediction (low/medium/high) by GDI for primary immunodeficiency autosomal dominant diseases,,,Medium; High; Low,N,,,,,N,,,,
164,GDP_PID_AR,dbNSFP,4.0c,Gene damage prediction (PID AR disease-causing genes),gene damage prediction (low/medium/high) by GDI for primary immunodeficiency autosomal recessive diseases,,,Medium; High; Low,N,,,,,N,,,,
165,GDP_cancer,dbNSFP,4.0c,Gene damage prediction (all cancer disease-causing genes),gene damage prediction (low/medium/high) by GDI for all cancer disease,,,Medium; High; Low,N,,,,,N,,,,
166,GDP_cancer_rec,dbNSFP,4.0c,Gene damage prediction (cancer recessive disease-causing genes),gene damage prediction (low/medium/high) by GDI for cancer recessive disease,,,Medium; High; Low,N,,,,,N,,,,
167,GDP_cancer_dom,dbNSFP,4.0c,Gene damage prediction (cancer dominant disease-causing genes),gene damage prediction (low/medium/high) by GDI for cancer dominant disease,,,Medium; High; Low,N,,,,,N,,,,
168,LoFtool_score,dbNSFP,4.0c,LoF,a percentile score for gene intolerance to functional change. The lower the score the higher gene intolerance to functional change. For details see doi: 10.1093/bioinformatics/btv602.,,,8.87E-01; 3.86E-01; 9.26E-01; 5.01E-01; 4.21E-01; 2.93E-01; 9.50E-01; 5.85E-01; 3.04E-01; 8.40E-01,N,,,,,N,,,,
169,SORVA_LOF_MAF0.005_HetOrHom,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Heterozygote or Homozygote of LOF SNVs whose MAF<0.005. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 3.9936102236421724E-4; 0.0023961661341853034; 0.001597444089456869; 0.0011980830670926517; 0.00439297124600639; 7.987220447284345E-4; 0.003993610223642172; 0.006789137380191693; 0.009584664536741214,N,,,,,N,,,,
170,SORVA_LOF_MAF0.005_HomOrCompoundHet,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Compound Heterozygote or Homozygote of LOF SNVs whose MAF<0.005. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 7.987220447284345E-4; 3.9936102236421724E-4; 0.001996805111821086; 0.0011980830670926517; 0.0023961661341853034; 0.006389776357827476; 0.001597444089456869; 0.003194888178913738; 0.008386581469648562,N,,,,,N,,,,
171,SORVA_LOF_MAF0.001_HetOrHom,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Heterozygote or Homozygote of LOF SNVs whose MAF<0.001. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 3.9936102236421724E-4; 0.0023961661341853034; 0.001597444089456869; 0.0011980830670926517; 7.987220447284345E-4; 0.003993610223642172; 0.005191693290734824; 0.001996805111821086; 0.003194888178913738,N,,,,,N,,,,
172,SORVA_LOF_MAF0.001_HomOrCompoundHet,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Compound Heterozygote or Homozygote of LOF SNVs whose MAF<0.001. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 3.9936102236421724E-4; 0.001996805111821086; 0.0011980830670926517; 0.0027955271565495207; 7.987220447284345E-4; 0.001597444089456869,N,,,,,N,,,,
173,SORVA_LOForMissense_MAF0.005_HetOrHom,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Heterozygote or Homozygote of LOF or missense SNVs whose MAF<0.005. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 0.022763578274760384; 0.0762779552715655; 0.06589456869009584; 0.024361022364217253; 0.05151757188498403; 0.03274760383386582; 0.00718849840255591; 0.16853035143769968; 0.034345047923322686,N,,,,,N,,,,
174,SORVA_LOForMissense_MAF0.005_HomOrCompoundHet,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Compound Heterozygote or Homozygote of LOF or missense SNVs whose MAF<0.005. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 0.00439297124600639; 0.0059904153354632585; 0.008386581469648562; 7.987220447284345E-4; 0.005191693290734824; 0.001996805111821086; 0.003194888178913738; 0.017971246006389777; 0.001597444089456869,N,,,,,N,,,,
175,SORVA_LOForMissense_MAF0.001_HetOrHom,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Heterozygote or Homozygote of LOF or missense SNVs whose MAF<0.001. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 0.008386581469648562; 0.036741214057507986; 0.04153354632587859; 0.019169329073482427; 0.03634185303514377; 0.03154952076677316; 0.010782747603833865; 0.00718849840255591; 0.07707667731629393,N,,,,,N,,,,
176,SORVA_LOForMissense_MAF0.001_HomOrCompoundHet,dbNSFP,4.0c,,the fraction of individuals in the 1000 Genomes Project data (N=2504) who are either Compound Heterozygote or Homozygote of LOF or missense SNVs whose MAF<0.001. This fraction is from a method for ranking genes based on mutational burden called SORVA (Significance Of Rare VAriants). Please see doi: 10.1101/103218 for details.,,,0.0; 0.001996805111821086; 0.001597444089456869; 3.9936102236421724E-4; 7.987220447284345E-4; 0.0023961661341853034; 0.00439297124600639; 0.003594249201277955; 0.0011980830670926517; 0.004792332268370607,N,,,,,N,,,,
177,Essential_gene,dbNSFP,4.0c,Essential gene (MGI),Essential ('E') or Non-essential phenotype-changing ('N') based on Mouse Genome Informatics database. from doi:10.1371/journal.pgen.1003484,,,N; E,N,,,,,N,,,,
178,Essential_gene_CRISPR,dbNSFP,4.0c,Essential gene (CRISPR),Essential ('E') or Non-essential phenotype-changing ('N') based on large scale CRISPR experiments. from doi: 10.1126/science.aac7041,,,N; E,N,,,,,N,,,,
179,Essential_gene_CRISPR2,dbNSFP,4.0c,Essential gene (CRISPR2),"Essential ('E'), context-Specific essential ('S'), or Non-essential phenotype-changing ('N') based on large scale CRISPR experiments. from http://dx.doi.org/10.1016/j.cell.2015.11.015",,,N; E; S,N,,,,,N,,,,
180,Essential_gene_gene-trap,dbNSFP,4.0c,Essential gene (gene-trap),"Essential ('E'), HAP1-Specific essential ('H'), KBM7-Specific essential ('K'), or Non-essential phenotype-changing ('N'), based on large scale mutagenesis experiments. from doi: 10.1126/science.aac7557",,,N; H; E; K,N,,,,,N,,,,
181,Gene_indispensability_score,dbNSFP,4.0c,,A probability prediction of the gene being essential. From doi:10.1371/journal.pcbi.1002886,,,0.114371359811310; 0.000683535100850493; 0.187549044243291; 0.946496023965855; 0.323193869751981; 0.259498654175253; 0.99544852671045; 0.893955099408202; 0.88298741376669; 0.0884618892570334,N,,,,,N,,,,
182,Gene_indispensability_pred,dbNSFP,4.0c,,Essential ('E') or loss-of-function tolerant ('N') based on Gene_indispensability_score.,,,N; E,N,,,,,N,,,,
185,ZFIN_zebrafish_gene,dbNSFP,4.0c,Zebrafish gene (ZFIN),Homolog zebrafish gene name from ZFIN,V1,,noc2l; agrn; sdf4; ints11; mmp23bb; gnb1a; prkcz; skia; rer1; her2,N,,,,,N,,,,
186,ZFIN_zebrafish_structure,dbNSFP,4.0c,Zebrafish structure (ZFIN),Affected structure of the homolog zebrafish gene from ZFIN,V1,,anatomical system; CaP motoneuron; dorsal longitudinal anastomotic vessel; hemopoiesis; liver; neuromast; bulbus arteriosus; retinal rod cell; trunk; cardiac muscle cell,N,,,,,N,,,,
187,ZFIN_zebrafish_phenotype_quality,dbNSFP,4.0c,Zebrafish phenotype quality (ZFIN),Phenotype description for the homolog zebrafish gene from ZFIN,V1,,quality; decreased length; aplastic; disrupted; decreased size; decreased amount; amorphous; bent; process quality; absent,N,,,,,N,,,,
188,ZFIN_zebrafish_phenotype_tag,dbNSFP,4.0c,Zebrafish phenotype tag (ZFIN),Phenotype tag for the homolog zebrafish gene from ZFIN,V1,,abnormal; ameliorated; exacerbated,N,,,,,N,,,,
193,mu_mis,gnomADmetrics,v2.1.1,,,,,4.1668e-06; 2.0713e-05; 2.9346e-05; 3.1317e-05; 2.4060e-05; 2.4195e-05; 4.1431e-06; 8.0856e-06; 9.9464e-05; 7.7410e-06,N,,,,,N,,,,
194,possible_mis,gnomADmetrics,v2.1.1,,,,,1978; 4156; 4856; 4083; 3802; 4345; 1473; 1057; 12779; 1522,N,,,,,N,,,,
195,obs_mis_pphen,gnomADmetrics,v2.1.1,,,,,29; 132; 140; 167; 135; 110; 30; 31; 342; 12,N,,,,,N,,,,
196,exp_mis_pphen,gnomADmetrics,v2.1.1,,,,,3.1909e+01; 9.0043e+01; 1.3562e+02; 1.7558e+02; 9.7727e+01; 9.7787e+01; 3.0382e+01; 3.1318e+01; 3.9487e+02; 2.1509e+01,N,,,,,N,,,,
197,oe_mis_pphen,gnomADmetrics,v2.1.1,,,,,9.0884e-01; 1.4660e+00; 1.0323e+00; 9.5114e-01; 1.3814e+00; 1.1249e+00; 9.8741e-01; 9.8985e-01; 8.6611e-01; 5.5790e-01,N,,,,,N,,,,
198,possible_mis_pphen,gnomADmetrics,v2.1.1,,,,,776; 1102; 1490; 1558; 1147; 1182; 389; 337; 3727; 407,N,,,,,N,,,,
202,mu_syn,gnomADmetrics,v2.1.1,,,,,1.7760e-06; 9.2699e-06; 1.3672e-05; 1.6269e-05; 1.1429e-05; 1.2220e-05; 1.9868e-06; 4.4670e-06; 4.9630e-05; 3.7764e-06,N,,,,,N,,,,
203,possible_syn,gnomADmetrics,v2.1.1,,,,,607; 1486; 1471; 1359; 1323; 1611; 588; 363; 4373; 579,N,,,,,N,,,,
207,mu_lof,gnomADmetrics,v2.1.1,,,,,9.6530e-08; 1.3068e-06; 2.1537e-06; 1.6488e-06; 1.5693e-06; 1.0314e-06; 1.5251e-07; 4.7048e-08; 5.0007e-06; 9.0400e-08,N,,,,,N,,,,
208,possible_lof,gnomADmetrics,v2.1.1,,,,,60; 285; 447; 292; 332; 204; 49; 12; 963; 38,N,,,,,N,,,,
209,pLI,gnomADmetrics,v2.1.1,pLI,the probability of being loss-of-function intolerant (intolerant of both heterozygous and homozygous lof variants) based on gnomAD v2,,,3.0354e-02; 4.7681e-14; 2.8933e-29; 1.3052e-16; 1.1549e-14; 1.1667e-15; 1.3746e-05; 4.0527e-01; 5.4727e-07; 2.6565e-02,N,,,,,N,,,,
210,pNull,gnomADmetrics,v2.1.1,pNull,,,,3.5740e-01; 9.4979e-01; 9.9995e-01; 9.7837e-01; 8.5111e-01; 9.9702e-01; 8.7001e-01; 1.1604e-01; 1.4068e-12; 3.8803e-01,N,,,,,N,,,,
211,pRec,gnomADmetrics,v2.1.1,pRec,,,,6.1225e-01; 5.0208e-02; 5.2786e-05; 2.1625e-02; 1.4889e-01; 2.9832e-03; 1.2998e-01; 4.7870e-01; 1.0000e+00; 5.8541e-01,N,,,,,N,,,,
212,oe_syn_lower,gnomADmetrics,v2.1.1,,,,,6.7900e-01; 1.5370e+00; 1.4640e+00; 1.6410e+00; 1.1070e+00; 1.1000e+00; 1.0170e+00; 8.8400e-01; 1.1330e+00; 9.2600e-01,N,,,,,N,,,,
213,oe_syn_upper,gnomADmetrics,v2.1.1,,,,,1.2580e+00; 1.8750e+00; 1.7610e+00; 1.9390e+00; 1.3850e+00; 1.3770e+00; 1.5950e+00; 1.3360e+00; 1.2810e+00; 1.4250e+00,N,,,,,N,,,,
214,oe_mis_lower,gnomADmetrics,v2.1.1,,,,,6.6400e-01; 1.4050e+00; 1.1660e+00; 9.9800e-01; 1.1680e+00; 9.9600e-01; 9.7000e-01; 8.7000e-01; 9.3800e-01; 9.9400e-01,N,,,,,N,,,,
215,oe_mis_upper,gnomADmetrics,v2.1.1,,,,,9.9300e-01; 1.6190e+00; 1.3380e+00; 1.1630e+00; 1.3580e+00; 1.1690e+00; 1.3420e+00; 1.1790e+00; 1.0290e+00; 1.3350e+00,N,,,,,N,,,,
216,oe_lof_lower,gnomADmetrics,v2.1.1,,,,,3.2500e-01; 6.4000e-01; 8.0500e-01; 6.6400e-01; 5.8500e-01; 8.3700e-01; 8.1600e-01; 0.0000e+00; 2.3700e-01; 3.5200e-01,N,,,,,N,,,,
217,oe_lof_upper,gnomADmetrics,v2.1.1,,,,,1.8400e+00; 1.2800e+00; 1.3270e+00; 1.2590e+00; 1.1240e+00; 1.6860e+00; 1.9470e+00; 1.6910e+00; 4.3500e-01; 1.8670e+00,N,,,,,N,,,,
218,constraint_flag,gnomADmetrics,v2.1.1,Constraint flag (gnomAD),,,,mis_too_many|syn_outlier; syn_outlier; mis_too_many; no_exp_lof; mis_too_many|no_exp_lof; mis_too_many|no_exp_lof|syn_outlier; lof_too_many|mis_too_many; no_exp_lof|syn_outlier; no_variants; lof_too_many,Y,,,,,N,,,,
219,syn_z,gnomADmetrics,v2.1.1,Z score (synonymous),,,,3.5753e-01; -6.9212e+00; -6.7147e+00; -8.8090e+00; -2.4681e+00; -2.3898e+00; -1.3661e+00; -5.0008e-01; -3.9572e+00; -8.1312e-01,N,,,,,N,,,,
220,mis_z,gnomADmetrics,v2.1.1,Z score (missense),,,,6.1403e-01; -3.4361e+00; -1.9010e+00; -5.7094e-01; -1.7988e+00; -5.5519e-01; -4.6973e-01; -4.4129e-02; 2.2552e-01; -5.5496e-01,N,,,,,N,,,,
221,lof_z,gnomADmetrics,v2.1.1,Z score (LoF),,,,2.0421e-01; 4.7484e-01; -1.7417e-01; 4.5884e-01; 1.0089e+00; -7.1321e-01; -1.2182e+00; 9.7435e-01; 6.0143e+00; 6.4099e-02,N,,,,,N,,,,
222,oe_lof_upper_rank,gnomADmetrics,v2.1.1,,,,,17847; 13738; 14172; 13521; 12118; 16725; 18996; 16766; 4022; 18109,N,,,,,N,,,,
223,oe_lof_upper_bin,gnomADmetrics,v2.1.1,,,,,9; 7; 6; 8; 2; 4; 1; 3; 5; NA,N,,,,,N,,,,
224,oe_lof_upper_bin_6,gnomADmetrics,v2.1.1,,,,,5; 4; 3; 1; 2; NA; 0,N,,,,,N,,,,
225,n_sites,gnomADmetrics,v2.1.1,,,,,0; 34; 70; 33; 50; 8; 45; 7; 29; 9,N,,,,,N,,,,
226,classic_caf,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.9574e-03; 8.1459e-04; 2.4370e-04; 8.7804e-04; 1.8299e-04; 2.7434e-04; 3.4378e-05; 2.5172e-03; 1.2909e-04,N,,,,,N,,,,
227,max_af,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.1243e-03; 1.8303e-04; 5.2832e-05; 2.5184e-04; 7.2816e-05; 3.3964e-05; 9.3434e-06; 1.6688e-03; 4.0444e-05,N,,,,,N,,,,
228,no_lofs,gnomADmetrics,v2.1.1,,,,,0; 125204; 125546; 125310; 125455; 124573; 125566; 125216; 125180; 124996,N,,,,,N,,,,
229,obs_het_lof,gnomADmetrics,v2.1.1,,,,,0; 446; 201; 60; 177; 44; 64; 8; 562; 32,N,,,,,N,,,,
230,obs_hom_lof,gnomADmetrics,v2.1.1,,,,,0; 11; 1; 5; 6; 449; 4; NA; 7; 20,N,,,,,N,,,,
231,defined,gnomADmetrics,v2.1.1,,,,,0; 125661; 125747; 125370; 125633; 124617; 125630; 125224; 125028; 124553,N,,,,,N,,,,
232,p,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.8200e-03; 7.9954e-04; 2.3932e-04; 7.0866e-04; 1.7656e-04; 2.5475e-04; 3.1943e-05; 2.2571e-03; 1.2798e-04,N,,,,,N,,,,
233,exp_hom_lof,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 4.1626e-01; 8.0386e-02; 7.1805e-03; 6.3093e-02; 3.8846e-03; 8.1530e-03; 1.2778e-04; 6.4060e-01; 2.0478e-03,N,,,,,N,,,,
234,classic_caf_afr,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 5.1398e-03; 6.8242e-04; 2.7152e-03; 1.3773e-04; 2.5951e-04; 7.0349e-03; 5.6840e-04; 1.2817e-04; 6.1652e-05,N,,,,,N,,,,
235,classic_caf_amr,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.4034e-03; 4.3436e-04; 2.3435e-04; 2.0908e-04; 8.8595e-05; 4.5574e-04; 1.2367e-04; 7.6515e-04; 2.9097e-05,N,,,,,N,,,,
236,classic_caf_asj,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 6.1387e-04; 4.2758e-03; 1.0898e-04; 4.1102e-04; 1.0428e-04; 5.1493e-04; 2.0421e-04; 9.9681e-05; 2.6499e-02,N,,,,,N,,,,
237,classic_caf_eas,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 8.4838e-03; 9.3132e-04; 2.1891e-04; 2.8479e-04; 1.1039e-03; 1.6640e-04; 2.1430e-02; 5.4807e-05; 1.0928e-04,N,,,,,N,,,,
238,classic_caf_fin,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 4.9778e-04; 4.6194e-05; 2.7009e-04; 9.9890e-05; 1.9800e-04; 1.9082e-03; 3.6979e-04; 1.5074e-02; 1.9856e-04,N,,,,,N,,,,
239,classic_caf_nfe,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.2324e-03; 8.3002e-04; 3.7926e-04; 5.8498e-04; 1.1713e-04; 3.2021e-04; 1.7989e-05; 6.2696e-04; 9.8368e-05,N,,,,,N,,,,
240,classic_caf_oth,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.6858e-03; 1.3339e-03; 1.6426e-04; 7.3836e-04; 1.6892e-04; 2.8384e-03; 2.0438e-03; 1.6502e-04; 3.3763e-04,N,,,,,N,,,,
241,classic_caf_sas,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.0732e-03; 5.0007e-04; 1.6406e-04; 2.8601e-03; 2.3060e-04; 1.3681e-04; 3.2678e-05; 2.4477e-04; 2.9418e-04,N,,,,,N,,,,
242,p_afr,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 4.8134e-03; 6.7690e-04; 2.5889e-03; 1.2583e-04; 2.4631e-04; 6.3563e-03; 5.5909e-04; 1.2532e-04; 6.1533e-05,N,,,,,N,,,,
243,p_amr,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.3309e-03; 4.3372e-04; 2.3135e-04; 2.0239e-04; 8.7112e-05; 4.3377e-04; 1.1577e-04; 7.2297e-04; 2.8931e-05,N,,,,,N,,,,
244,p_asj,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 5.9577e-04; 4.2750e-03; 9.9369e-05; 3.9730e-04; 1.0003e-04; 4.9883e-04; 1.9962e-04; 9.9310e-05; 2.6543e-02,N,,,,,N,,,,
245,p_eas,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 7.9700e-03; 9.2464e-04; 2.1758e-04; 2.7189e-04; 1.0457e-03; 1.6318e-04; 1.9434e-02; 5.4414e-05; 1.0874e-04,N,,,,,N,,,,
246,p_fin,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 4.6204e-04; 4.6195e-05; 2.3099e-04; 9.2855e-05; 1.8483e-04; 1.8032e-03; 3.6962e-04; 1.4427e-02; 1.8479e-04,N,,,,,N,,,,
247,p_nfe,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.1448e-03; 8.0019e-04; 3.7124e-04; 5.1078e-04; 1.1556e-04; 2.9940e-04; 1.7709e-05; 5.0115e-04; 9.7642e-05,N,,,,,N,,,,
248,p_oth,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.4678e-03; 1.3038e-03; 1.6341e-04; 6.5253e-04; 1.6352e-04; 2.6093e-03; 1.9672e-03; 1.6368e-04; 3.2696e-04,N,,,,,N,,,,
249,p_sas,gnomADmetrics,v2.1.1,,,,,0.0000e+00; 1.0458e-03; 4.9006e-04; 1.6334e-04; 1.9944e-03; 2.2943e-04; 1.3067e-04; 3.2672e-05; 2.2866e-04; 2.9408e-04,N,,,,,N,,,,
250,transcript_level,gnomADmetrics,v2.1.1,,,,,2; 3; 1,N,,,,,N,,,,
253,gene_type,gnomADmetrics,v2.1.1,,,,,protein_coding; polymorphic_pseudogene,N,,,,,N,,,,
254,gene_length,gnomADmetrics,v2.1.1,,,,,918; 19696; 15106; 5129; 9369; 6919; 1211; 1118; 35994; 3342,N,,,,,N,,,,
255,exac_pLI,gnomADmetrics,v2.1.1,,,,,1.7633e-01; 1.3538e-10; 1.3304e-19; 2.5168e-07; 2.0197e-08; NA; 1.4794e-04; 9.8478e-03; 1.7335e-01; 9.0878e-02,N,,,,,N,,,,
256,exac_obs_lof,gnomADmetrics,v2.1.1,,,,,1; 17; 29; 13; 15; NA; 5; 3; 2; 8,N,,,,,N,,,,
257,exac_exp_lof,gnomADmetrics,v2.1.1,,,,,2.2177e+00; 2.0005e+01; 2.8884e+01; 1.8832e+01; 2.1150e+01; NA; 3.4895e+00; 3.5107e+00; 5.4417e+01; 4.3923e+00,N,,,,,N,,,,
258,exac_oe_lof,gnomADmetrics,v2.1.1,,,,,4.5091e-01; 8.4979e-01; 1.0040e+00; 6.9030e-01; 7.0923e-01; NA; 1.4329e+00; 8.5454e-01; 2.3890e-01; 4.5534e-01,N,,,,,N,,,,